TWM587175U - Fermenter of the yogurt bio beverage - Google Patents

Fermenter of the yogurt bio beverage Download PDF

Info

Publication number
TWM587175U
TWM587175U TW108209275U TW108209275U TWM587175U TW M587175 U TWM587175 U TW M587175U TW 108209275 U TW108209275 U TW 108209275U TW 108209275 U TW108209275 U TW 108209275U TW M587175 U TWM587175 U TW M587175U
Authority
TW
Taiwan
Prior art keywords
yogurt
extract
temperature
extracts
tank
Prior art date
Application number
TW108209275U
Other languages
Chinese (zh)
Inventor
錢佑
張登豪
張灝
丘錦朋
黃建誠
凃鴻宇
杜英齊
呂美津
許育銘
Original Assignee
宇洋生物醫學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宇洋生物醫學股份有限公司 filed Critical 宇洋生物醫學股份有限公司
Priority to TW108209275U priority Critical patent/TWM587175U/en
Publication of TWM587175U publication Critical patent/TWM587175U/en

Links

Landscapes

  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The application discloses a fermenter of a yogurt bio beverage, wherein the fermenter includes a sealed top cover and a tank, the tank is covered by the sealed top cover, and thus an inner space is formed. The inner space produces the yogurt bio beverage had excellent sensory evaluation and effects of free radical clearance, anti-oxidation, high reduction capability, and the inhibition of cancer cell growth.

Description

優格生技飲品的發酵機 Yogurt biotech beverage fermentation machine

本創作關於一種發酵機,尤其本創作關於一種具抗氧化與抑制消化道癌細胞生長的優格生技飲品的發酵機。 This creation is about a fermenter, especially about a fermenter for yoge biotech drinks with anti-oxidation and inhibition of the growth of digestive tract cancer cells.

腸-腦之間的雙向訊息網路稱為腸-腦軸(gut-brain axis),後來又發現腸道的共生菌群對此腸-腦軸具有貢獻,三者互相影響,因此成為共生菌-腸-腦軸(microbiota-gut-brain axis)。美國國家精神衛生研究院(NIMH)於2013年啟動探索腸道微生物群-大腦交流機制的特別計畫,目的為開發抗精神疾病的新藥以及非侵入性治療方法。從那時起,共生菌-腸-腦軸的相關研究如雨後春筍般展開,成為神經科學研究之焦點,主軸為探討腸道微生物群與大腦之間的相互作用。腸道微生物群透過神經網路、神經內分泌系統及免疫系統對大腦產生重要影響,而人體行為的擾動也會改變腸道微生物群的組成。文獻已報導共生菌-腸-腦軸的相互平衡關係,並證實與多種疾病相關,例如:發炎性腸道疾病(inflammatory bowel disease,IBD)、胃腸道癌症、膽石症、行為障礙、焦慮、憂鬱、慢性疲勞症候群(chronic fatigue syndrome,CFS)、肝性腦病變(hepatic encephalopathy)、過敏、肥胖、糖尿病、動脈粥樣硬化等。在癌症化療及手術後的照護上,人體臨床研究已報導藉由調控腸道微生物群的組成能改善乳癌患者的心肺健康及降低癌症復發恐懼(fear of cancer recurrence)。 The intestinal-brain two-way information network is called the gut-brain axis. Later, it was discovered that the intestinal symbiotic flora contributed to this intestinal-brain axis. The three affected each other, so they became symbiotic bacteria. -Intestinal-brain axis (microbiota-gut-brain axis). The National Institute of Mental Health (NIMH) launched a special project in 2013 to explore the gut microbiota-brain communication mechanism, with the goal of developing new anti-psychotic drugs and non-invasive treatments. Since then, related research on the symbiotic bacteria-gut-brain axis has sprung up and has become the focus of neuroscience research. The main axis is to explore the interaction between the gut microbiota and the brain. The gut microbiota has important effects on the brain through neural networks, neuroendocrine systems, and the immune system, and disturbances in human behavior also change the composition of the gut microbiota. The literature has reported a symbiotic-intestinal-brain axis balance and has been linked to a variety of diseases, such as: inflammatory bowel disease (IBD), gastrointestinal cancer, gallstones, behavioral disorders, anxiety, Depression, chronic fatigue syndrome (CFS), hepatic encephalopathy, allergy, obesity, diabetes, atherosclerosis, etc. In cancer chemotherapy and post-operative care, human clinical studies have reported that by regulating the composition of the gut microbiota, it can improve the cardiopulmonary health of breast cancer patients and reduce the fear of cancer recurrence.

目前,西醫及中醫體系正積極發展、或結合共生菌-腸-腦軸 的研究進行藥物開發、疾病治療及其作用機轉的研究;而另一醫療系統-阿育吠陀(Ayurveda)使用大量薑黃於改善消化道不適、神經保護、預防阿茲海默症,其多樣性的功效也與腸-腦軸有相關。但由於飲食習慣不同,薑黃的使用有區域性的限制,主要在印度。 At present, western and traditional Chinese medicine systems are actively developing or combining symbiotic bacteria-gut-brain axis Research on drug development, disease treatment and its mechanism of action; and Ayurveda, another medical system, uses a large amount of turmeric to improve gastrointestinal discomfort, neuroprotection, and prevention of Alzheimer's, its diversity The efficacy is also related to the gut-brain axis. However, due to different eating habits, the use of turmeric has regional restrictions, mainly in India.

在西醫體系中,利用共生菌-腸-腦軸研究進行藥物開發稱之為微生態藥物,其係指利用正常微生物或調節微生物正常生長的物質所製成的藥物製劑。可應用於感染、糖尿病、腫瘤、發炎疾病、免疫相關疾病等適應症。微生態藥物包括:活體生物藥(live biotherapeutic product,LBP)、小分子微生態調節劑(small molecule microbiome modulator,SMMM)、糞菌移植(fecal microbiota transplant,FMT)。其中,LBP係指透過對人體微生物的鑑定、篩選及組合而明確控制菌體種類及數量,針對不同適應症採用不同菌體種類、數量及其組合來確保用藥的安全性及有效性。然而,美國食品藥物管理局(FDA)至今尚未批准任何LBP上市,只在2016年發佈LBP的早期臨床試驗指南,使得LBP的開發具有明確標準。SMMM係指能夠選擇性促進宿主腸道的一或多種有益細菌生長繁殖的物質,藉由影響菌體的生長繁殖達成治療目的。目前已知的SMMM藥物開發只到臨床二期。FMT則是指將健康人體糞便的功能菌群移植至患者胃腸道,重建患者的腸道菌群,以進行腸道及腸道外疾病的治療。雖然美國已於2013年將FMT列入復發性困難梭狀桿菌感染(Clostridium difficile infection)的治療指南,但不同國家的政策差異大,FMT目前缺乏統一及有效的監管。整體而言,微生態藥物的臨床試驗進展不如預期,目前尚無批准上市的微生態藥物。另一問題是微生態藥物的臨床試驗人數相對較少,藥物療效的人體驗證仍不如預期。 In the western medical system, the use of symbiotic-intestinal-brain axis research for drug development is called micro-ecological drugs, which refer to pharmaceutical preparations made of normal microorganisms or substances that regulate the normal growth of microorganisms. Can be used for indications such as infection, diabetes, tumors, inflammatory diseases, and immune-related diseases. Microecological medicines include: live biotherapeutic product (LBP), small molecule microbiome modulator (SMMM), fecal microbiota transplant (FMT). Among them, LBP refers to the explicit control of the type and number of bacterial cells through the identification, screening and combination of human microorganisms, and the use of different types, numbers and combinations of bacterial cells for different indications to ensure the safety and effectiveness of medication. However, the U.S. Food and Drug Administration (FDA) has not yet approved any LBP to market, and only issued guidelines for early clinical trials of LBP in 2016, which makes the development of LBP a clear standard. SMMM refers to a substance that can selectively promote the growth and reproduction of one or more beneficial bacteria in the intestine of the host, and achieve therapeutic purposes by affecting the growth and reproduction of bacteria. Currently known SMMM drug development is only in clinical phase II. FMT refers to transplanting the functional flora of healthy human feces into the gastrointestinal tract of a patient and reconstructing the intestinal flora of the patient for the treatment of intestinal and extra-intestinal diseases. Although the United States included FMT in the guidelines for the treatment of recurrent Clostridium difficile infection in 2013, the policies of different countries vary widely, and FMT currently lacks unified and effective supervision. In general, the clinical trials of micro-ecological drugs have not progressed as expected, and there are currently no micro-ecological drugs approved for marketing. Another problem is that the number of clinical trials of micro-ecological drugs is relatively small, and human verification of the efficacy of the drugs is still not as expected.

中醫體系並非利用共生菌-腸-腦軸研究開發藥物,而是研究中藥與腸道微生物群的相互作用。中藥對於腸道微生物群的調節作用例如:含有多醣的補益類中藥對於益菌及病原菌具有扶植作用,但對於益菌 的扶植效果明顯優於病原菌,而生長良好的益菌所產生的代謝物又間接抑制病原菌生長。例如,黨參多醣在體外可促進雙歧桿菌生長,進而增加乙酸代謝,增強雙歧桿菌的定殖抗性(colonization resistance)。腸道微生物群對於中藥的代謝作用例如:目前已證實許多中藥成分只有經過腸道微生物群的代謝才產生藥效成分而達到治療效果。例如,黃芩所含的黃芩苷(baicalin)在腸道內難以被直接吸收,只有被腸道微生物群水解為黃芩素(baicalein)才能被吸收進入血液而發揮作用。人體臨床試驗證實,葛根芩連湯可藉由改變腸道微生物群治療第二型糖尿病。整體而言,共生菌-腸-腦軸的中藥研究提供了西方醫學可接受的作用機轉解釋,但仍無法改善中藥因劑量太高、治療時間太長而導致服藥順從性(drug compliance)及服藥依順性(medication adherence)皆低的老問題。 The traditional Chinese medicine system does not use symbiotic-intestinal-brain axis research to develop drugs, but studies the interaction between traditional Chinese medicine and intestinal microbiota. Regulating effects of traditional Chinese medicine on intestinal microflora, for example: supplementary Chinese medicines containing polysaccharides have beneficial effects on beneficial bacteria and pathogenic bacteria, but on beneficial bacteria The planting effect is significantly better than that of pathogenic bacteria, and metabolites produced by well-growing beneficial bacteria indirectly inhibit the growth of pathogenic bacteria. For example, Codonopsis pilosula polysaccharide can promote the growth of Bifidobacterium in vitro, thereby increasing the metabolism of acetic acid, and enhancing the colonization resistance of Bifidobacterium. Intestinal microbiota's metabolic effect on traditional Chinese medicine, for example: It has been confirmed that many traditional Chinese medicine components can only produce medicinal active ingredients and achieve therapeutic effect only after being metabolized by intestinal microbiota. For example, baicalin contained in Scutellaria Baicalensis is difficult to be directly absorbed in the intestinal tract. Only baicalein hydrolyzed by the intestinal microbiota can be absorbed into the blood to function. Human clinical trials have confirmed that Gegen Qinlian Decoction can treat type 2 diabetes by altering the gut microbiota. Overall, the study of commensal bacteria-gut-brain axis in traditional Chinese medicine provided an acceptable explanation of the mechanism of action in western medicine, but it still failed to improve the compliance and drug compliance of traditional Chinese medicines due to high doses and long treatment times. The old problem of low medication adherence.

上述西醫、中醫及阿育吠陀醫療系統對於共生菌-腸-腦軸的研究與開發著重在疾病、藥物及治療。整體而言,這些發展仍處於萌芽期,尚未具有產業上成功案例或具規模的量產。因此,仍須開發新穎可應用於共生菌-腸-腦軸的產品及技術,以達生物醫學的功效。 The research and development of the symbiotic bacteria-gut-brain axis by the aforementioned western medicine, traditional Chinese medicine, and Ayurveda medical systems focus on diseases, drugs, and treatments. On the whole, these developments are still in their infancy, and have not yet had industrial success stories or large-scale mass production. Therefore, it is still necessary to develop new products and technologies that can be applied to the symbiotic bacteria-gut-brain axis in order to achieve the efficacy of biomedicine.

本案申請人鑑於習知技術中的不足,經過悉心試驗與研究,並一本鍥而不捨的精神,終構思出本案,能夠克服先前技術的不足,以下為本案的簡要說明。 In view of the shortcomings in the conventional technology, the applicant of this case has conscientiously experimented and researched, and devoted himself to this case. He conceived this case and can overcome the shortcomings of the prior art. The following is a brief description of this case.

本創作之目的為提供一種優格飲品,包括:動物乳汁製品及複數菌粉,動物乳汁製品包括水及動物乳汁,複數菌粉與動物乳汁製品相混合,其中複數菌粉來自於對應的複數種菌株,複數種菌株包括:長雙岐桿菌(Bifidobacterium longum)、嗜酸乳桿菌(Lactobacillus acidophilus)、副乾酪乳桿菌(Lactobacillus paracasei)以及鼠李糖桿菌(Lactobacillus rhamnosus)。 The purpose of this creation is to provide a Yogurt drink, including: animal milk products and multiple bacteria powders, animal milk products including water and animal milk, multiple bacteria powders and animal milk products are mixed, in which multiple bacteria powders come from the corresponding multiple species Strains, multiple strains include: Bifidobacterium longum , Lactobacillus acidophilus , Lactobacillus paracasei , and Lactobacillus rhamnosus .

前述優格飲品更包括由下列菌株所組成的群組:比菲德氏菌(Bifidobacterium bifidum)、短雙岐桿菌(Bifidobacterium breve)、嬰兒雙岐桿菌(Bifidobacterium infantis)、雷特氏雙岐桿菌(Bifidobacterium lactis)、糞腸球菌(Enterococcus faecium)、乾酪乳桿菌(Lactobacillus casei)、保加利亞乳桿菌(Lactobacillus delbrueckii subsp.bulgaricus)、發酵乳桿菌(Lactobacillus fermentum)、瑞士乳桿菌(Lactobacillus helveticus)、植物乳桿菌(Lactobacillus plantarum)、唾液乳酸桿菌(Lactobacillus salivarius)以及嗜熱鏈球菌(Streptococcus thermophilus)。 The aforementioned Yogurt drink further includes a group consisting of the following strains: Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium infantis , Bifidobacterium ret Bifidobacterium lactis), Enterococcus faecalis (Enterococcus faecium), Lactobacillus casei (Lactobacillus casei), Lactobacillus bulgaricus (Lactobacillus delbrueckii subsp. bulgaricus), Lactobacillus fermentum (Lactobacillus fermentum), Switzerland Lactobacillus (Lactobacillus helveticus), Lactobacillus ( Lactobacillus plantarum ), Lactobacillus salivarius , and Streptococcus thermophilus .

本創作之另一目的為提供一種前述優格飲品的分離方法,包括:冷凍乾燥該優格飲品,獲得粉狀產物;以正己烷萃取粉狀產物,獲得正己烷萃取物及第一殘留物,其中正己烷萃取物的主量成分為具有雙鍵及氫氧基的短鏈脂肪酸;以乙酸乙酯萃取第一殘留物,獲得乙酸乙酯萃取物及第二殘留物,其中乙酸乙酯萃取物的主量成分為糖脂;以乙醇萃取第二殘留物,獲得乙醇萃取物及第三殘留物,其中乙醇萃取物的主量成分包括雙醣及寡醣;以及以水萃取第三殘留物,獲得水萃取物及第四殘留物,其中水萃取物的主量成分包括多醣、醣蛋白以及蛋白質。 Another purpose of this creation is to provide a method for separating the aforementioned Yogurt drink, comprising: freeze-drying the Yogurt drink to obtain a powdery product; extracting the powdery product with n-hexane to obtain a n-hexane extract and a first residue, The main component of the n-hexane extract is a short-chain fatty acid having a double bond and a hydroxyl group; the first residue is extracted with ethyl acetate to obtain an ethyl acetate extract and a second residue, wherein the ethyl acetate extract The main component of Glycolipids; extracting the second residue with ethanol to obtain an ethanol extract and a third residue, wherein the main components of the ethanol extract include disaccharides and oligosaccharides; and extracting the third residue with water, A water extract and a fourth residue are obtained, wherein the main components of the water extract include polysaccharides, glycoproteins, and proteins.

本創作的另一目的為提供一種將前述優格飲品用於抑制癌細胞生長的用途,其中癌細胞選自由血癌細胞、腦癌細胞、胃癌細胞、大腸癌細胞及/或其組合。 Another object of the present invention is to provide a use of the aforementioned Yogurt drink for inhibiting the growth of cancer cells, wherein the cancer cells are selected from the group consisting of blood cancer cells, brain cancer cells, gastric cancer cells, colorectal cancer cells, and / or combinations thereof.

本創作揭露一種用於製備優格飲品的發酵機,包括:槽體、密封頂蓋。密封頂蓋與槽體組裝,使密封頂蓋與槽體所圍設的一空間為密閉。投料口設置於密封頂蓋上,水、奶粉以及菌粉經由投料口被送入該空間。電機控制器設置於槽體外,攪拌馬達耦接於電機控制器,攪拌臂設置於該空間內且連接於攪拌馬達,用以攪拌水、奶粉以及菌粉。電阻增溫器設置於槽體外且耦接於電機控制器,用以消毒水及奶粉,並使菌粉在水以及奶粉所形成的混合物中於37℃至43℃之間進行發酵,製備成該優格飲品。 This creation discloses a fermentation machine for preparing yogurt drinks, which includes a tank body and a sealed top cover. The sealing top cover is assembled with the tank body, so that a space surrounded by the sealing top cover and the tank body is sealed. The feeding opening is arranged on the sealed top cover, and water, milk powder and bacterial powder are sent into the space through the feeding opening. The motor controller is disposed outside the tank, the stirring motor is coupled to the motor controller, and the stirring arm is disposed in the space and connected to the stirring motor for stirring water, milk powder and bacterial powder. The resistance warmer is arranged outside the tank and is coupled to the motor controller, for disinfecting water and milk powder, and fermenting the bacteria powder in a mixture of water and milk powder at 37 ° C to 43 ° C to prepare the Yogurt drinks.

在本創作中,發酵機還包括槽體底部的出料口,優格飲品由出料口送出。槽體外的控溫夾層,與電阻增溫器連接,控溫夾層受電阻增溫器的控制而調整或維持該空間的溫度。密封頂蓋上還包括清洗口,槽體側邊包括導熱流入口,槽體底部包括導熱流出口。 In this creation, the fermentation machine also includes a discharge port at the bottom of the tank, and Yogurt drinks are sent out from the discharge port. The temperature-controlling interlayer outside the tank is connected with the resistance warmer, and the temperature-controlling interlayer is controlled by the resistance-heater to adjust or maintain the temperature of the space. The sealing top cover further includes a cleaning port, the side of the tank body includes a heat conduction flow inlet, and the bottom of the tank body includes a heat conduction flow outlet.

在本創作中,發酵機還包括耦接於電機控制器的感溫探測器,電機控制器還包括一螢幕,感溫探測器感測的溫度顯示在螢幕上。密封頂蓋還包括觀察窗,用以供使用者目視槽體內的狀況。 In this creation, the fermentation machine also includes a temperature detector coupled to the motor controller. The motor controller also includes a screen, and the temperature detected by the temperature detector is displayed on the screen. The sealed top cover also includes an observation window for the user to visually observe the conditions in the tank.

本文用語「動物乳汁製品」大體上包括水及動物乳汁,動物乳汁可以液態形式存在,或是經巴斯德滅菌法而乾燥為粉末形式,且動物乳汁的來源可為入乳、牛乳或羊奶等。 The term "animal milk products" herein generally includes water and animal milk. Animal milk can be in liquid form or dried into powder form by pasteurization. The source of animal milk can be milk, cow's milk or goat's milk. Wait.

本文的各種細菌菌株及癌症細胞株均可透過市售方式取得,並無須進行生物材料寄存。本文的優格飲品在冷藏及室溫環境下為液態。本文優格飲品中的菌株在37℃至43℃的溫度及8小時至12小時的發酵時間呈現不等的發酵結果。 The various bacterial strains and cancer cell lines in this article can be obtained through commercial means, and there is no need to deposit biological materials. The Yogurt drink in this article is liquid under refrigerated and room temperature environments. In this paper, the strains in Yogurt beverages showed different fermentation results at a temperature of 37 ° C to 43 ° C and a fermentation time of 8 hours to 12 hours.

3‧‧‧分離方法 3‧‧‧ separation method

12‧‧‧優格飲品原液 12‧‧‧Youge Drink Stock Solution

14‧‧‧粉狀產物 14‧‧‧ powder product

16‧‧‧正己烷萃取物 16‧‧‧ n-hexane extract

18‧‧‧第一殘留物 18‧‧‧ first residue

20‧‧‧乙酸乙酯萃取物 20‧‧‧ ethyl acetate extract

22‧‧‧第二殘留物 22‧‧‧Second residue

24‧‧‧乙醇萃取物 24‧‧‧ ethanol extract

26‧‧‧第三殘留物 26‧‧‧Third residue

28‧‧‧水萃取物 28‧‧‧water extract

30‧‧‧第四殘留物 30‧‧‧ Fourth residue

100‧‧‧發酵機 100‧‧‧ Fermenter

101‧‧‧槽體 101‧‧‧ tank

102‧‧‧控溫夾層 102‧‧‧Temperature control interlayer

103‧‧‧電阻增溫器 103‧‧‧ resistance warmer

104‧‧‧攪拌臂 104‧‧‧mixing arm

105‧‧‧密封頂蓋 105‧‧‧Sealed top cover

106‧‧‧清洗口 106‧‧‧washing mouth

107‧‧‧感溫探測器 107‧‧‧Temperature detector

108‧‧‧電機控制器 108‧‧‧Motor controller

109‧‧‧螢幕 109‧‧‧Screen

110‧‧‧攪拌馬達 110‧‧‧mixing motor

M‧‧‧投料口 M‧‧‧feeding port

N4‧‧‧出料口 N4‧‧‧ discharge port

N5‧‧‧導熱流入口 N5‧‧‧Heat conduction inlet

N6‧‧‧導熱流出口 N6‧‧‧ Thermal Outlet

S1‧‧‧觀察窗 S1‧‧‧Viewing window

第1圖為菌種代號LR-36的16S rDNA定序結果及NCBI比對結果,為鼠李糖桿菌(Lactobacillus rhamnosus)。 Figure 1 shows the 16S rDNA sequencing result and NCBI comparison result of strain code LR-36, which is Lactobacillus rhamnosus .

第2圖為菌種代號LPL-68的16S rDNA定序結果及NCBI比對結果,為植物乳桿菌(Lactobacillus plantarum)。 Figure 2 shows the 16S rDNA sequencing result and NCBI comparison result of the strain code LPL-68, which is Lactobacillus plantarum .

第3圖(A)為菌種代號UY-58的顯微照片。為革蘭氏陽性桿菌,不具觸酶、氧化酶及運動性,不會產生內生孢子,於好氧及厭氧環境下皆會生長。 Figure 3 (A) is a photomicrograph of the strain code UY-58. It is a Gram-positive bacillus. It does not have enzymes, oxidases, and motility, and does not produce endospores. It will grow in both aerobic and anaerobic environments.

第3圖(B)為菌種代號UY-58的16S rDNA定序結果。最接近發酵乳桿菌(Lactobacillus fermentum),相似性為99.9%。 Figure 3 (B) is the 16S rDNA sequencing result of strain code UY-58. It is closest to Lactobacillus fermentum , and the similarity is 99.9%.

第4圖(A)為菌種代號UY-76的顯微照片。為革蘭氏陽性桿菌,不具觸 酶、氧化酶及運動性,不會產生內生孢子,於好氧及厭氧環境下皆會生長。 Figure 4 (A) is a photomicrograph of the strain code UY-76. Gram-positive bacilli Enzymes, oxidases, and motility do not produce endospores, and they grow in both aerobic and anaerobic environments.

第4圖(B)為菌種代號UY-76的16S rDNA定序結果。最接近瑞士乳桿菌(Lactobacillus helveticus),相似性為100%。 Figure 4 (B) is the 16S rDNA sequencing result of strain code UY-76. It is closest to Lactobacillus helveticus and the similarity is 100%.

第5圖為分離方法3的流程圖。 FIG. 5 is a flowchart of the separation method 3.

第6圖(A)為優格飲品11正己烷萃取物(11-H)的1H-NMR圖譜。 FIG. 6 (A) is a 1 H-NMR spectrum of 11 n-hexane extract (11-H) of Yogurt Beverage.

第6圖(B)為優格飲品11乙酸乙酯萃取物(11-E)的1H-NMR圖譜。 Figure 6 (B) is a 1 H-NMR spectrum of 11 ethyl acetate extract (11-E) of Yogurt Beverage.

第6圖(C)為優格飲品11乙醇萃取物(11-A)的1H-NMR圖譜。 Figure 6 (C) is the 1 H-NMR spectrum of the 11 ethanol extract (11-A) of Yogurt Beverage.

第6圖(D)為優格飲品11水萃取物(11-W)的1H-NMR圖譜。 Figure 6 (D) is the 1 H-NMR spectrum of the 11 water extract (11-W) of Yogurt Beverage.

第7圖(A)為優格飲品12正己烷萃取物(12-H)的1H-NMR圖譜。 Fig. 7 (A) is a 1 H-NMR spectrum of the 12 n-hexane extract (12-H) of Yogurt Beverage.

第7圖(B)為優格飲品12乙酸乙酯萃取物(12-E)的1H-NMR圖譜。 Figure 7 (B) is a 1 H-NMR spectrum of the 12 ethyl acetate extract (12-E) of Yogurt Beverage.

第7圖(C)為優格飲品12乙醇萃取物(12-A)的1H-NMR圖譜。 Figure 7 (C) is the 1 H-NMR spectrum of the 12 ethanol extract (12-A) of Yogurt Beverage.

第7圖(D)為優格飲品12水萃取物(12-W)的1H-NMR圖譜。 Figure 7 (D) is the 1 H-NMR spectrum of the water extract (12-W) of Yogurt Beverage.

第8圖(A)為優格飲品13正己烷萃取物(13-H)的1H-NMR圖譜。 FIG. 8 (A) is a 1 H-NMR spectrum of 13 n-hexane extract (13-H) of Yogurt Beverage.

第8圖(B)為優格飲品13乙酸乙酯萃取物(13-E)的1H-NMR圖譜。 Figure 8 (B) is the 1 H-NMR spectrum of the 13 ethyl acetate extract (13-E) of Yogurt Beverage.

第8圖(C)為優格飲品13乙醇萃取物(13-A)的1H-NMR圖譜。 Figure 8 (C) is the 1 H-NMR spectrum of the 13 ethanol extract (13-A) of Yogurt Beverage.

第8圖(D)為優格飲品13水萃取物(13-W)的1H-NMR圖譜。 Figure 8 (D) is the 1 H-NMR spectrum of the water extract (13-W) of Yogurt Beverage.

第9圖(A)為優格飲品14正己烷萃取物(14-H)的1H-NMR圖譜。 FIG. 9 (A) is a 1 H-NMR spectrum of the 14 n-hexane extract (14-H) of Yogurt Beverage.

第9圖(B)為優格飲品14乙酸乙酯萃取物(14-E)的1H-NMR圖譜。 Figure 9 (B) is a 1 H-NMR spectrum of the 14 ethyl acetate extract (14-E) of Yogurt Beverage.

第9圖(C)為優格飲品14乙醇萃取物(14-A)的1H-NMR圖譜。 FIG. 9 (C) is a 1 H-NMR spectrum of Yogurt 14 ethanol extract (14-A).

第9圖(D)為優格飲品14水萃取物(14-W)的1H-NMR圖譜。 Figure 9 (D) is the 1 H-NMR spectrum of the water extract (14-W) of Yogurt Beverage.

第10圖為優格飲品11至14經分離方法3所獲得各萃取物的總多酚含量分析柱狀圖。 Figure 10 is a histogram of the total polyphenol content of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第11圖為優格飲品11至14經分離方法3所獲得各萃取物的總flavanone類黃酮含量分析柱狀圖。 Figure 11 is a histogram of the total flavanone flavonoid content of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第12圖為優格飲品11至14經分離方法3所獲得各萃取物的總多醣含量分析柱狀圖。 Figure 12 is a histogram of the total polysaccharide content of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第13圖為優格飲品11經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 FIG. 13 is an HPLC spectrum of each extract at 203 nm obtained by separation method 3 of Yogurt Drink 11.

第14圖為優格飲品12經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 Figure 14 shows the HPLC spectrum of each extract at 203 nm obtained by separation method 3 of Yogurt Beverage 12.

第15圖為優格飲品13經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 FIG. 15 is an HPLC spectrum of each extract at 203 nm obtained by separation method 3 of Yogurt Drink 13.

第16圖為優格飲品14經分離方法3所獲得各萃取物在203nm波長的HPLC圖譜。 FIG. 16 is an HPLC spectrum of each extract at 203 nm obtained by separation method 3 of Yogurt Beverage 14.

第17圖為優格飲品11至14經分離方法3所獲得各萃取物的DPPH自由基清除率柱狀圖。 Figure 17 is a histogram of DPPH free radical scavenging rate of each extract obtained by separation method 3 of Yogurt beverages 11 to 14.

第18圖為優格飲品11至14經分離方法3所獲得各萃取物的總抗氧化能力-ABTS自由基清除率柱狀圖。 FIG. 18 is a histogram of total antioxidant capacity-ABTS free radical scavenging rate of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第19圖為優格飲品11至14經分離方法3所獲得各萃取物的還原力測定柱狀圖。 FIG. 19 is a histogram of the reducing power of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第20圖為優格飲品11至14經分離方法3所獲得各萃取物的血癌細胞存活抑制率柱狀圖。 FIG. 20 is a histogram of the survival inhibition rate of blood cancer cells of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第21圖為優格飲品11至14經分離方法3所獲得各萃取物的腦癌細胞存活抑制率柱狀圖。 FIG. 21 is a histogram of the survival inhibition rate of brain cancer cells of each extract obtained by separation method 3 of Yogurt Drinks 11 to 14.

第22圖為優格飲品11至14經分離方法3所獲得各萃取物的胃癌細胞存活抑制率柱狀圖。 FIG. 22 is a histogram of the survival inhibition rate of gastric cancer cells of each extract obtained by separation method 3 of Yogurt Drinks 11 to 14.

第23圖為優格飲品11至14經分離方法3所獲得各萃取物的大腸癌細胞存活抑制率柱狀圖。 FIG. 23 is a histogram of the survival inhibition rate of colorectal cancer cells of each extract obtained by separation method 3 of Yogurt drinks 11 to 14.

第24圖為優格飲品11至14經分離方法3所獲得各萃取物的前列腺癌細胞存活抑制率柱狀圖。 FIG. 24 is a histogram of the survival inhibition rate of prostate cancer cells of each extract obtained by separation method 3 of Yogurt Drinks 11 to 14.

第25圖為優格飲品生產系統流程圖。 Figure 25 is a flowchart of Yogurt beverage production system.

第26圖為本創作具抗氧化與抑制消化道癌細胞生長的優格飲品發酵機 之示意圖。 Picture 26: Yogurt Beverage Fermentor with Antioxidant and Inhibition of Digestive Tract Cancer Cell Growth The schematic.

本創作的上述目的及優點在參閱以下詳細說明及附圖之後對那些所屬技術領域中具有通常知識者將變得更立即地顯而易見。 The above objects and advantages of the present invention will become more immediately apparent to those having ordinary knowledge in the technical field after referring to the following detailed description and accompanying drawings.

本創作將優格的活性代謝物進行活性導引分離,確定活性成分並調製成適合口服的飲品或藥劑,且仍保持成分的功效。 In this creation, the active metabolites of Yogurt are separated by active guidance, and the active ingredients are determined and prepared into beverages or medicaments suitable for oral administration, while still maintaining the efficacy of the ingredients.

實驗1、菌種的分離與鑑定:Experiment 1. Isolation and identification of strains:

取1ml的生牛乳作為樣品,以乳酸桿菌MRS培養基(Lactobacilli MRS Broth)作為稀釋液進行10倍連續稀釋(濃度倍數分別為10-1、10-2、10-3、10-4),分別取200μl稀釋物滴於無菌MRS洋菜培養基,再進行塗盤。將培養皿置於37℃厭氧培養箱培養24小時。之後無菌挑選型態、顏色、大小不同的單一菌落繼續培養,並反覆挑選菌落及培養以分離菌種,確定培養皿上的菌落皆為相同形態、顏色、大小。最後將分離的單一菌株進行菌種保存及鑑定。優格菌種的鑑定係先以肉眼觀察培養皿上為單一菌落,再挑選二個相同菌落進行格蘭氏染色,確定為格蘭氏陽性或陰性菌。較佳地是以相位差顯微鏡於4及40倍倍數下觀察菌落。挑選單一菌落進行DNA萃取及16S PCR試驗,以NCBI資料庫比對序列,由其結果完成鑑定。 Take 1ml of raw cow's milk as a sample, use Lactobacilli MRS Broth as a dilution solution to make a 10-fold serial dilution (concentration multiples of 10 -1 , 10 -2 , 10 -3 , 10 -4 ), respectively 200 μl of the dilution was dropped on sterile MRS agar culture medium, and then plated. The petri dish was cultured in an anaerobic incubator at 37 ° C for 24 hours. After that, single colonies of different types, colors, and sizes were selected aseptically and continued to be cultured, and colonies were repeatedly selected and cultured to isolate strains, and it was determined that the colonies on the Petri dish were all of the same shape, color, and size. Finally, the isolated single strain was stored and identified. The identification of Eugenic species was based on the observation of a single colony on the petri dish with the naked eye, and then two identical colonies were selected for Gram staining to determine that they were Gram-positive or negative. It is preferred to observe the colonies at 4 and 40 times multiples with a phase difference microscope. A single colony was selected for DNA extraction and 16S PCR test. The sequences were compared with the NCBI database, and the results were identified.

如第1及2圖所示,菌種代號LR-36以及LPL-68經16S rDNA定序及NCBI比對後,其分別為鼠李糖桿菌(Lactobacillus rhamnosus)以及植物乳桿菌(Lactobacillus plantarum)。此外,如第3圖(A)、第3圖(B)及表1所示,菌種代號UY-58經顯微鏡觀察鑑定、DNA萃取、16S rDNA定序(SEQ ID NO:1)、API 50 CHL鑑定,確認為革蘭氏陽性菌,且最接近發酵乳桿菌(Lactobacillus fermentum,相似性為99.9%)。第4圖(A)及第4圖(B)為菌種代號UY-76經顯微鏡觀察鑑定、DNA萃取、16S rDNA定序(SEQ ID NO:2)、API 50 CHL鑑定,確認為革蘭氏陽性桿菌,且最接近瑞士乳桿菌 (Lactobacillus helveticus,相似性為100%)。 As shown in Figures 1 and 2, after 16S rDNA sequencing and NCBI alignment, the strains LR-36 and LPL-68 were respectively Lactobacillus rhamnosus and Lactobacillus plantarum . In addition, as shown in Figure 3 (A), Figure 3 (B), and Table 1, the strain code UY-58 was identified by microscopic observation, DNA extraction, 16S rDNA sequencing (SEQ ID NO: 1), and API 50. CHL identification confirmed that it was a Gram-positive bacterium and closest to Lactobacillus fermentum (similarity was 99.9%). Figure 4 (A) and Figure 4 (B) are the strain code UY-76 identified by microscope observation, DNA extraction, 16S rDNA sequencing (SEQ ID NO: 2), API 50 CHL identification, and confirmed as Gram's Positive bacilli and closest to Lactobacillus helveticus (100% similarity).

經過分離、鑑定,共取得20株菌種,依拉丁文名稱順序排列如表3所示。 After isolation and identification, a total of 20 strains of strains were obtained.

實驗2、優格的發酵製備:Experiment 2: Fermentation of Yogurt:

本發明發酵製備實驗的設計模型是以菌種種類及比例、發酵溫度、及發酵時間為操縱變因,發酵後以黏度、酸鹼值(pH)為品管標準。優格黏度在100釐泊(cP)以下、pH值5.0以上判定為未發酵或發酵不完全,發酵時間過長(超過12小時)的實驗組因考量生產效率不佳也被淘汰。實驗2的製備方法為:將250ml之75℃熱水加入36g奶粉進行高溫殺菌,成為 動物乳汁製品。待其冷卻至35~43℃,加入0.3g菌粉。再分別置於不同溫度(37℃、40℃、43℃)培養箱反應不同時間(8小時、10小時、12小時),之後測量黏度(Brookfield DVE RV黏度計)與pH值(Milwaukee pH600酸鹼度計)。表4為14組成功發酵的菌種組合所含之菌株。 The design model of the fermentation preparation experiment of the present invention is based on the strain species type and ratio, fermentation temperature, and fermentation time as manipulation variables. After fermentation, viscosity and pH value are used as quality control standards. The experimental group with Yogurt viscosity below 100 centipoise (cP) and pH value above 5.0 was judged as unfermented or incompletely fermented, and the fermentation time was too long (more than 12 hours) due to poor production efficiency. The preparation method of Experiment 2 is: 250ml of 75 ° C hot water is added to 36g milk powder for high temperature sterilization, and becomes Animal milk products. Allow it to cool to 35-43 ° C and add 0.3 g of bacteria powder. Then put them in different temperature (37 ° C, 40 ° C, 43 ° C) incubator for different time (8 hours, 10 hours, 12 hours), then measure the viscosity (Brookfield DVE RV viscometer) and pH value (Milwaukee pH600 pH meter) ). Table 4 shows the strains contained in the 14 successfully fermented strain combinations.

結果發現,不同奶粉對於是否能成功發酵的影響不大;菌種種類之間的重量比例對於發酵結果影響亦不大。因此,各實驗組別菌種種類之間的(菌粉)重量比例皆為1:1,而菌種種類越多表明具有越容易成功發酵的趨勢,亦即菌種種類越多,成功發酵的實驗再現性越高。接著,以成功發酵再現性最高的4組(表4的菌種組合11至14)進行3重複實驗,確認不同菌種組合的最佳發酵條件(即,能在最短發酵時間內達到最高黏度與 最低pH值),優格黏度高於100cp、pH值低於5.0時,判定為發酵完全。實驗結果如表5所示。 It was found that the effect of different milk powders on the success of fermentation was not significant; the weight ratio between species of bacteria had little effect on the fermentation results. Therefore, the weight ratio of (bacterial powder) between the strains of each experimental group is 1: 1, and the more strains, the more likely it is to successfully ferment, that is, the more strains, the more successful the fermentation. The higher the experimental reproducibility. Next, 3 replicate experiments were performed with 4 groups with the highest reproducibility of successful fermentation (Table 4 strain combinations 11 to 14) to confirm the optimal fermentation conditions for different strain combinations (that is, the highest viscosity and The lowest pH value), when the Yogurt viscosity is higher than 100 cp and the pH value is lower than 5.0, it is judged that the fermentation is complete. The experimental results are shown in Table 5.

菌種組合11至14發酵製備的3重複實驗結果顯示: The results of three repeated experiments of fermentation of strain combinations 11 to 14 show that:

菌種組合11:發酵溫度固定為37℃,發酵時間需12小時才能發酵完全;發酵溫度固定為40℃,發酵時間10小時能發酵完全,發酵時間8、12小時無法發酵完全;發酵溫度固定為43℃,發酵時間10、12小時能發酵完全,發酵時間越長黏度越高、pH值越低。發酵時間固定為8小時,發酵溫度37、40、43℃皆無法發酵完全;發酵時間固定為10小時,發酵溫度40、43℃能發酵完全,發酵溫度越高黏度越低、pH值越高;發酵時間固定為12小時,發酵溫度37、43℃能發酵完全。 Bacterial combination 11: The fermentation temperature is fixed at 37 ° C, and the fermentation time needs 12 hours to complete the fermentation; the fermentation temperature is fixed at 40 ° C, the fermentation time is 10 hours to complete the fermentation, and the fermentation time 8 or 12 hours cannot be completely fermented; the fermentation temperature is fixed to Fermentation can be completed at 43 ° C for 10 or 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH. The fermentation time is fixed at 8 hours, and the fermentation temperature cannot be completed at 37, 40, and 43 ° C; the fermentation time is fixed at 10 hours, and the fermentation temperature can be completed at 40 and 43 ° C. The higher the fermentation temperature, the lower the viscosity and the higher the pH value; The fermentation time is fixed at 12 hours. The fermentation temperature is 37 and 43 ° C.

菌種組合12:發酵溫度固定為37℃,發酵時間10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度先低後高、pH值越低。發酵時間固定為8小時,發酵溫度40、43℃能發酵完全,發酵溫度越高黏度越低、pH值越高;發酵時間固定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高。 Bacterial combination 12: The fermentation temperature is fixed at 37 ° C, and the fermentation time can be completed in 10 and 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value; the fermentation temperature is fixed at 40 ° C, and the fermentation time is 8, 10, 12 All fermentation can be completed in hours, the longer the fermentation time, the higher the viscosity, the lower the pH value; the fermentation temperature is fixed at 43 ° C, and the fermentation time can be completed in 8, 10, 12 hours. The longer the fermentation time, the lower the viscosity, the higher the pH The lower the value. The fermentation time is fixed at 8 hours, and the fermentation temperature is 40, 43 ° C. It can be completely fermented. The higher the fermentation temperature, the lower the viscosity and the higher the pH value. The fermentation time is fixed at 10 hours, and the fermentation temperature is 37, 40, 43 ° C. The higher the fermentation temperature, the higher the viscosity, the lower the pH value, and then the higher value. The fermentation time is fixed at 12 hours. The fermentation temperature can be 37, 40, and 43 ° C. The higher the fermentation temperature, the higher the viscosity and then the lower the pH value. Low after high.

菌種組合13:發酵溫度固定為37℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度先低後高、pH值越低。發酵時間固定為8小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度越高、pH值越低;發酵時間固 定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先低後高、pH值先低後不變。 Bacterial combination 13: The fermentation temperature is fixed at 37 ° C, and the fermentation time can be completely completed at 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value; the fermentation temperature is fixed at 40 ° C and the fermentation time is 8 and 10 The fermentation can be completed in 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value. The fermentation temperature is fixed at 43 ° C. The fermentation time can be completed in 8, 10, and 12 hours. The longer the fermentation time, the lower the viscosity and then the higher the viscosity. , The lower the pH value. The fermentation time is fixed at 8 hours. The fermentation temperature can be completed at 37, 40, and 43 ° C. The higher the fermentation temperature, the higher the viscosity and the lower the pH value. Set to 10 hours, fermentation temperature can be complete at 37, 40, and 43 ° C. The higher the fermentation temperature, the higher the viscosity, the lower the pH value, and the lower the pH value. The fermentation time is fixed at 12 hours, and the fermentation temperature is 37, 40, and 43 ° C. All fermentation can be completed, the higher the fermentation temperature, the lower the viscosity, then the higher, the lower the pH value and then the same.

菌種組合14:發酵溫度固定為37℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為40℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值越低;發酵溫度固定為43℃,發酵時間8、10、12小時皆能發酵完全,發酵時間越長黏度越高、pH值不變。發酵時間固定為8小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先低後高、pH值越低;發酵時間固定為10小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後不變;發酵時間固定為12小時,發酵溫度37、40、43℃皆能發酵完全,發酵溫度越高黏度先高後低、pH值先低後高。 Bacterial combination 14: The fermentation temperature is fixed at 37 ° C, and the fermentation time can be completely completed at 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value; the fermentation temperature is fixed at 40 ° C and the fermentation time is 8 and 10 It can complete fermentation in 12 hours. The longer the fermentation time, the higher the viscosity and the lower the pH value. The fermentation temperature is fixed at 43 ° C. The fermentation time can be completed in 8, 10, and 12 hours. The longer the fermentation time, the higher the viscosity and pH. The value does not change. The fermentation time is fixed at 8 hours, and the fermentation temperature can be completed at 37, 40, and 43 ° C. The higher the fermentation temperature, the lower the viscosity and then the higher the pH value; the fermentation time is fixed at 10 hours and the fermentation temperature is 37, 40, 43 ° C. All fermentation can be completed, the higher the fermentation temperature, the higher the viscosity, the lower the pH value, and then the same; the fermentation time is fixed at 12 hours, and the fermentation temperature is 37, 40, and 43 ° C. After low, the pH value is low and then high.

實驗3、優格飲品的感官品評:Experiment 3. Sensory Evaluation of Yogurt Drinks:

優格對於維持身體健康具有多樣性的功效。例如,實驗證實,長期食用優格能有效降低總膽固醇以及總膽固醇與高密度脂蛋白膽固醇之比例;高膽固醇血症患者食用含嗜酸乳桿菌的優格能降低血清膽固醇;高膽固醇血症患者食用含嗜酸乳桿菌及長雙歧桿菌的優格可增加高密度膽固醇;長期食用優格可有效降低罹患糖尿病的風險;食用優格還能預防心血管疾病。因此,長期食用足夠量的優格方能達到維持身體健康功效。 Yogurt has a variety of effects on maintaining good health. For example, experiments have shown that long-term consumption of Yogurt can effectively reduce total cholesterol and the ratio of total cholesterol to high-density lipoprotein cholesterol; patients with hypercholesterolemia can reduce serum cholesterol by taking Yogurt containing Lactobacillus acidophilus; Consuming Yogurt containing Lactobacillus acidophilus and Bifidobacterium longum can increase high-density cholesterol; long-term consumption of Yogurt can effectively reduce the risk of diabetes; eating Yogurt can also prevent cardiovascular disease. Therefore, long-term consumption of sufficient amount of yogurt can achieve the effect of maintaining physical health.

為了達成上述目標,本發明將菌種組合1至14發酵製備為優格飲品1至14,並進行感官品評(sensory evaluation)的分析、篩選。感官品評為美國食品科技學會定義及發展出的評判基準,其應用視、嗅、嚐三種感覺來測量優格飲品的特性。感官品評的實驗設計包括:感官分析方法總論(ISO 6658:2005)、感官品評字彙(ISO 5492:2008)、顏色感官檢驗(目視比色:ISO 11037:1999)、質地感官檢驗(質地剖面:ISO 11036:1994)、風味感官檢驗(風味剖面:ISO 6564:1985)、描述分析(感官特性的定性描 述:ISO 11035:1994、感官特性強度的評估:ISO 4121:2003)。實驗方法則採用描述分析法(descriptive analysis)、順位評分法(ranking method)及喜好評分法(hedonic scale)進行評鑑。 In order to achieve the above-mentioned objectives, the present invention fermentes the strain combinations 1 to 14 to prepare Yogurt drinks 1 to 14 and performs sensory evaluation analysis and screening. Sensory products are evaluated and developed by the American Institute of Food Science and Technology. They use the three senses of sight, smell and taste to measure the characteristics of Yogurt beverages. The experimental design of sensory evaluation includes: general analysis of sensory analysis methods (ISO 6658: 2005), word vocabulary of sensory evaluation (ISO 5492: 2008), color sensory test (visual colorimetry: ISO 11037: 1999), texture sensory test (texture profile: ISO 11036: 1994), flavor sensory test (flavor profile: ISO 6564: 1985), descriptive analysis (qualitative description of sensory characteristics (Description: ISO 11035: 1994, Evaluation of sensory characteristic strength: ISO 4121: 2003). The experimental method uses descriptive analysis, ranking method and hedonic scale for evaluation.

1.以描述分析法進行優格飲品1至14的評鑑:1. Evaluation of Yogurt beverages 1 to 14 by descriptive analysis:

此是召集具有發酵產品開發、發酵乳製品開發、優格產品開發、手搖飲料店實務經驗之高感官敏銳性品評員11人進行實驗,其中男性5名、女性6名,以會議討論方式進行品評,判斷優格飲品間外觀、質地、風味上的差異性,最後以視(色澤、乾淨度)、嗅(奶香、香氣、氣味獨特性)、嚐(酸度、甜度、滑順度、醇厚度)、以及整體喜好(風味表現、後韻)描述差異性狀,採喜好度五分評分法(1分:非常不喜歡,2分:不喜歡,3分:不喜歡也不討厭,4分:喜歡,5分:非常喜歡)進行評價。實驗結果如表6所述。 This is a gathering of 11 highly sensory and sensitive judges with fermented product development, fermented dairy product development, yogurt product development, and hands-on beverage store practical experience, including 5 males and 6 females. Appraisal, judging the differences in appearance, texture and flavor among Yogurt beverages, and finally based on visual (color, cleanliness), smell (milk, aroma, unique smell), taste (acidity, sweetness, smoothness, Alcohol thickness), and overall preferences (flavor performance, aftertaste) describe the different traits, using a five-point scale of preference (1 point: very dislike, 2 points: dislike, 3 points: dislike and hate, 4 points : Like, 5 points: like very much). The experimental results are described in Table 6.

2.以順位評分法進行優格飲品1至14的評鑑:2. Evaluation of Yogurt Drinks 1 to 14 using the scoring method:

品評員的人數、性別如上所述,品評員依其喜好程度將優格飲品1至14區分為3個等級(喜好等級高、中、低),每個等級再依喜好程度最高至低由左至右排列。結果如表7所述。 The number and gender of the reviewers are as described above. The reviewers divide Yogurt beverages 1 to 14 into 3 levels according to their preferences (high, medium, and low preferences), and each level is based on the highest and lowest preferences from left to left. To the right. The results are shown in Table 7.

3.以喜好評分法進行優格飲品11至14的評鑑:3. Evaluation of Yogurt Drinks 11 to 14 by preference score method:

將順位評分法喜好等級高的優格飲品11至14再以喜好評分法確認是否有顯著性差異、了解喜好程度與產品特性關係,以消費者問卷調查方式進行,採喜好度五分評分法(1分:非常不喜歡,2分:不喜歡,3分:不喜歡也不討厭,4分:喜歡,5分:非常喜歡)進行評分。也針對香氣、甜味、酸味,以五分制(1分:太淡,2分:淡,3分:適中,4分:濃,5分:太濃)進行紀錄,分數越接近3分越佳。 The scoring method is used to rank 11 and 14 of Yogurt beverages with high preference level, and then confirm whether there is a significant difference with the preference scoring method, and understand the relationship between the degree of preference and product characteristics. 1 point: very dislike, 2 points: dislike, 3 points: dislike and hate, 4 points: like, 5 points: very like). It also records the aroma, sweetness, and sourness on a five-point scale (1 point: too light, 2 points: light, 3 points: moderate, 4 points: strong, 5 points: too strong), the closer the score is to 3, the more good.

第1次消費者問卷調查於百貨公司商店街舉行,此在不受外界環境干擾、彼此不互相影響下進行。品評對象為未經訓練之消費者共67人,其中男性24人(35.8%)、女性43人(64.2%)。年齡分布為:未滿20歲25人(37.3%)、20-29歲21人(31.3%)、30-39歲13人(19.4%)、40-49歲3人(4.5%)、50-59歲4人(6%)、60歲以上1人(1.5%)。前三大職業分佈為:學生30人(44.8%)、服務業17人(25.4%)、軍公教5人(7.4%),其餘15人(22.4%)。 The first consumer questionnaire survey was held in a department store shopping street. This was conducted without being disturbed by the external environment and without mutual influence. The evaluation target was 67 untrained consumers, including 24 males (35.8%) and 43 females (64.2%). The age distribution is: 25 people (37.3%) under 20 years old, 21 people (31.3%) 20-30 years old, 13 people (19.4%) 30-39 years old, 3 people (4.5%) 40-49 years old, 50- Four were 59 years old (6%), and one was over 60 years old (1.5%). The top three occupations are: 30 students (44.8%), 17 in the service industry (25.4%), 5 in military education (7.4%), and the remaining 15 (22.4%).

第2次消費者問卷調查於大學學區舉行,此亦在不受外界環境干擾、彼此不互相影響下進行。品評對象為未經訓練之消費者共69人, 其中男性31人(44.9%)、女性38人(55.1%)。年齡分佈為:18-22歲50人(72.5%)、23-30歲15人(21.8%)、未滿18歲4人(5.8%)。職業分佈皆為學生(69人,100%)。 The second consumer questionnaire survey was held in the university school district, and this was also conducted without interference from the external environment and without mutual influence. The evaluation target is a total of 69 untrained consumers. There were 31 males (44.9%) and 38 females (55.1%). The age distribution was: 50 people (72.5%) between 18-22 years old, 15 people (21.8%) between 23-30 years old, and 4 people (5.8%) under 18 years old. The occupation distribution is all students (69, 100%).

綜合第1次及第2次消費者問卷調查結果,參與總人數為136人。請參閱表8,整體喜好程度以優格飲品14最佳,分數為大於4分的喜歡;其次為優格飲品12;優格飲品11、13的分數相近,分數皆大於3分的不喜歡也不討厭。此外,優格飲品11、12、13及14被全部136位消費者評定為最喜好(第一順位)之優格飲品的人數分別為32、38、31及35人。 Based on the results of the first and second consumer questionnaires, the total number of participants was 136. Please refer to Table 8. The overall preference is Yogurt Drink 14 with a score of more than 4 likes, followed by Yogurt Drink 12; Yogurt Drinks 11 and 13 have similar scores, and those who have scores greater than 3 also dislike. it's OK. In addition, Yogurt Drinks 11, 12, 13 and 14 were rated by all 136 consumers as their favorite (first place). The number of Yogurt Drinks was 32, 38, 31 and 35 respectively.

在純天然、未加入任何調味料的製程下,優格飲品11至14的香氣差異不大,都稍微偏淡;優格飲品11至14的甜味皆適中;優格飲品11至14的酸味差異不大,都稍微偏淡(如表9結果所示)。 In the pure natural process without any seasoning, the aroma difference of Yogurt beverages 11 to 14 is not much, and they are slightly lighter; the sweetness of Yogurt beverages 11 to 14 is moderate; the sourness of Yogurt beverages 11 to 14 The difference is not large, and all are slightly faint (as shown in the results in Table 9).

實驗4、優格飲品配料的感官品評:Experiment 4. Sensory evaluation of ingredients for yogurt

為了增加優格飲品食用上的多樣性、提高使用者每日的優格攝取量(例如能在30分鐘內喝完200g)且長期飲用不膩口,實驗4以優格飲品14為基底加入手搖飲料的配方設計,並以描述分析法進行評鑑。實驗4召集具有發酵產品開發、發酵乳製品開發、優格產品開發、手搖飲料店實務經驗之高感官敏銳性品評員5人進行實驗,其中男性3人、女性2人,並以會 議討論方式進行品評。 In order to increase the variety of Yogurt beverages, increase the daily Yogurt intake of the user (for example, 200g in 30 minutes), and not greasy after long-term drinking, Experiment 4 added Yogurt 14 as the base. Shake the beverage formula and evaluate with descriptive analysis. Experiment 4 convened 5 high-sensory and sensitive judges with fermented product development, fermented dairy product development, Youge product development, and hand-operated beverage store practical experience, including 3 males and 2 females. Discuss the way to discuss and evaluate.

1.鹹甜口味的優格飲品配方設計:1. Recipe design of yog drink with salty and sweet taste:

加入芝麻醬為醬汁:芝麻醬熬煮後加入優格共同打碎研磨,芝麻醬香味濃郁,含有油脂,兩者相容後風味含有油脂味,使整體風味產生鹹食口感,但風味過於特異,接受度不高。加入小黃瓜為配料:小黃瓜切丁加入優格共同打碎研磨,小黃瓜風味掩蓋優格風味,整體蔬菜味明顯,缺少優格的獨特風味。加入玉米為配料:將無調味玉米罐頭之玉米粒加入優格共同打碎研磨,玉米略帶甜味,可提升整體甜味,但玉米風味與優格風味融合為一種特殊味道,接受度甚低。感官品評結果:優格飲品的配方設計不適合鹹甜口味。 Add sesame sauce as the sauce: After the sesame sauce is boiled, add Yogurt to break and grind. The sesame sauce is rich in flavor and contains oil. After the two are compatible, the flavor contains oily taste, which makes the overall flavor produce a salty taste. not tall. Gherkin is added as an ingredient: diced cucumber and yoghurt are crushed and ground together. The flavor of the cucumber masks the yoghurt flavor. The overall vegetable flavor is obvious and lacks the unique flavor of yoghurt. Add corn as an ingredient: Add the unflavored canned corn kernels to Yogurt and crush and grind them together. The corn is slightly sweet and can improve the overall sweetness, but the flavor of corn and Yogurt are combined into a special flavor with low acceptance. . Sensory evaluation results: The formula design of Yogurt drinks is not suitable for salty and sweet flavors.

2.優格飲品醬汁的配方設計:2. The formula design of Yogurt sauce:

本發明的優格飲品製程純天然、且未加任何調味料,整體風味上甜味適中、香氣及酸味稍微偏淡,屬於淡雅不膩口型。不同醬汁配方帶來不同的感官感受。加入黑糖為醬汁:將熬煮成糖漿的黑糖加入優格共同打碎研磨,黑糖風味濃郁且特殊,與優格酸甜風味正好相容。加入抹茶為醬汁:將日本進口抹茶粉加入優格共同打碎研磨,抹茶微苦,與優格酸甜風味並不相容。加入蜂蜜為漿汁:將蜂蜜直接加入優格共同打碎研磨,蜂蜜特有的清香能凸顯優格的酸甜風味。 The Yogurt beverage of the present invention has a pure and natural manufacturing process without any seasoning. The overall flavor is moderately sweet, and the aroma and sour taste are slightly lighter, which belongs to an elegant and not greasy mouth shape. Different sauce recipes bring different sensory sensations. Add brown sugar as sauce: add brown sugar boiled into syrup to Yogurt and crush and grind. The brown sugar has a strong and special flavor, which is compatible with the sweet and sour flavor of Yogurt. Add matcha tea as a sauce: Add matcha powder imported from Japan to Yogurt and crush and grind it. The matcha tea is slightly bitter, which is not compatible with Yogurt's sweet and sour flavor. Add honey to the juice: Add honey directly to Yogurt and crush and grind it. The unique fragrance of honey can highlight the sweet and sour flavor of Yogurt.

3.優格飲品固態配料的配方設計:3. Formula design of solid ingredients for yogurt

優格飲品屬於非牛頓流體(non-Newtonian fluid,係指在某特定溫度及壓力下流體的黏滯性為非定值),其黏度會因所受壓力或速度而變化,壓力越大,黏度增加,甚至成為暫時性固體。若加入固態配料於優格飲品將造成飲用及吸食上的困難。為克服此問題,將200g優格飲品容納於圓柱杯(上圓直徑9公分,下圓直徑5.6公分,杯高13.5公分),讓使用者可利用直徑1~1.5公分、長17.5~20公分的吸管輕鬆吸食優格飲品中的固態配料,且不會發生飲品已喝完卻殘留下固態配料的現象。在較佳實施例中, 在室溫下,優格飲品的溫度升高會影響黏度進而影響以吸管吸食固態配料的難易度。因此,在優格飲品的上層加入碎冰層保冷(碎冰大小控制在0.2~0.4立方公分之間,因為小於0.2立方公分會太快融化出水,大於0.4立方公分會吸到碎冰塊口感不佳),碎冰層和優格飲品的體積比為1:3~1:5,使優格飲品在30分鐘內維持在8~12℃之間,使固態配料的感官品評結果具再現性。固態配料感官品評的評估重點為:口感的滑順度、整體的均衡度;進一步包括視覺的刺激感,提升使用者觀看而想飲用優格飲品的欲望(促進食慾、增強主動攝取)。優格飲品外觀可呈現分層、漸層、特殊紋路的效果。所添加的固態配料包括但不限於珍珠、椰果、咖啡凍、粉條、芋圓、布丁、仙草凍、豆花、綠豆、紅豆、薏仁、紫米、燕麥,其感官品評的結果如表10所述。此外,亦可使用水果作為固態配料,包括但不限於西瓜、芒果、草莓、荔枝、火龍果、百香果、酪梨、香蕉、木瓜、奇異果、柳橙、葡萄柚、鳳梨,其感官品評的結果如表11所示。 Yogurt drinks are non-Newtonian fluids (non-Newtonian fluids are fluids with a non-constant value at a certain temperature and pressure). Their viscosity will change due to the pressure or speed. The greater the pressure, the higher the viscosity. Increase or even become temporary solid. Adding solid ingredients to Yogurt beverages will cause difficulties in drinking and smoking. In order to overcome this problem, 200g Yogurt beverages are accommodated in cylindrical cups (diameter of the upper circle is 9 cm, diameter of the lower circle is 5.6 cm, and cup height is 13.5 cm). The straws can easily suck the solid ingredients in Yogurt beverages, and the phenomenon of solid ingredients remaining after drinking the beverage will not occur. In the preferred embodiment, At room temperature, the temperature increase of Yogurt beverages will affect the viscosity and thus the difficulty of sucking solid ingredients with a straw. Therefore, add crushed ice to the upper layer of yogurt to keep cold. Good), the volume ratio of crushed ice layer and Yogurt drink is 1: 3 ~ 1: 5, so that Yogurt drink is maintained between 8 ~ 12 ℃ within 30 minutes, and the sensory evaluation results of solid ingredients are reproducible. The evaluation focus of the solid ingredient sensory evaluation is: smoothness of the taste and overall balance; further including visual stimulus, which enhances the user's desire to watch and drink Yogurt beverages (promote appetite, enhance active intake). The appearance of Yogurt drinks can show the effects of layering, gradation and special texture. The added solid ingredients include, but are not limited to, pearl, coconut fruit, coffee jelly, vermicelli, taro, pudding, frozen grass jelly, bean curd, mung bean, red bean, barley kernel, purple rice, oatmeal. The results of sensory evaluation are shown in Table 10. Described. In addition, fruits can also be used as solid ingredients, including but not limited to watermelon, mango, strawberry, lychee, dragon fruit, passion fruit, avocado, banana, papaya, kiwi, orange, grapefruit, and pineapple. The results are shown in Table 11.

實驗5、優格飲品萃取物的製備:Experiment 5. Preparation of Yogurt Beverage Extract:

優格飲品活性代謝物的種類及含量受菌種、配方、發酵環境而有所差異。為了確定本發明的優格飲品的活性成分,選擇感官品評喜好等級高的優格飲品11至14進行萃取及分配萃取,將獲得的劃分層再進行成分分析及活性測試。 The types and contents of active metabolites in Yogurt beverages vary depending on the strain, formula, and fermentation environment. In order to determine the active ingredients of the Yogurt beverage of the present invention, Yogurt beverages 11 to 14 with high sensory appraisal preferences are selected for extraction and partition extraction, and the obtained divided layers are further subjected to component analysis and activity testing.

1.分離方法1:1. Separation method 1:

將優格飲品原液以加熱減壓濃縮進行乾燥,獲得膏狀物。再 以乙醇連續萃取膏狀物3次,獲得乙醇萃取物。將該乙醇萃取物真空過濾,並加熱、減壓濃縮,獲得粗萃取物。再以乙酸乙酯:水(1:1(v/v))對粗萃取物進行分配萃取。但粗萃取物乳化層太多,導致分離效果不佳,無法進行後續分離實驗。若改以二氯甲烷:水(1:1(v/v))對粗萃取物進行分配萃取,仍有乳化層太多的問題。 The yogurt beverage stock solution was concentrated under heating and reduced pressure to dry, to obtain a paste. again The paste was continuously extracted three times with ethanol to obtain an ethanol extract. The ethanol extract was filtered under vacuum, heated, and concentrated under reduced pressure to obtain a crude extract. The crude extract was partitioned and extracted with ethyl acetate: water (1: 1 (v / v)). However, there are too many emulsified layers of the crude extract, resulting in poor separation effect, and subsequent separation experiments cannot be performed. If dichloromethane: water (1: 1 (v / v)) is used for partition extraction of the crude extract, there is still a problem of too many emulsified layers.

2.分離方法2:2. Separation method 2:

將優格飲品原液不經乾燥,而是加水(1:1(v/v))稀釋,再加入乙酸乙酯(1:1(v/v))進行分配萃取,仍產生大量乳化層,導致分離效果不佳。若改為加入二氯甲烷(1:1(v/v))或者正丁醇(1:1(v/v))進行分配萃取,仍有乳化層太多的問題。 The yogurt liquid was not dried, but diluted with water (1: 1 (v / v)), and then added with ethyl acetate (1: 1 (v / v)) for partition extraction. A large amount of emulsified layer was still produced, resulting in The separation effect is not good. If dichloromethane (1: 1 (v / v)) or n-butanol (1: 1 (v / v)) is added instead for partition extraction, there is still a problem of too many emulsified layers.

3.分離方法3:3. Separation method 3:

將優格飲品原液進行冷凍乾燥,獲得粉狀產物,再將粉狀產物以極性漸增的溶媒依序進行萃取。發現二氯甲烷的萃取率太低、和正己烷的萃取效果無顯著差異,以正丁醇萃取後有溶媒殘留的問題、難接續後續的溶媒萃取,故二氯甲烷、正丁醇皆不適合作為此分離方法的萃取溶媒。 The yogurt liquid is freeze-dried to obtain a powdery product, and the powdery product is sequentially extracted with a solvent of increasing polarity. It is found that the extraction rate of dichloromethane is too low, and there is no significant difference between the extraction effect of n-hexane. The solvent residue problem after n-butanol extraction is difficult to continue the subsequent solvent extraction. Therefore, neither dichloromethane nor n-butanol is suitable as Extraction solvent for this separation method.

如第5圖所示的分離方法3,經溶媒排列組合萃取試驗後,最後以正己烷、乙酸乙酯、乙醇及水依序進行萃取。亦即,優格飲品原液12進行冷凍乾燥,獲得粉狀產物14,再以正己烷萃取粉狀產物14,獲得正己烷萃取物16(樣品代號:11-H、12-H、13-H、14-H)及第一殘留物18。接著,以乙酸乙酯萃取第一殘留物18,獲得乙酸乙酯萃取物20(樣品代號:11-E、12-E、13-E、14-E)及第二殘留物22。之後,以乙醇萃取第二殘留物22,獲得乙醇萃取物24(樣品代號:11-A、12-A、13-A、14-A)及第三殘留物26。最後,再以水萃取第三殘留物26,獲得水萃取物28(樣品代號:11-W、12-W、13-W、14-W)及第四殘留物30。萃取物及殘留物並得各自進行加熱減壓濃縮。優格飲品11至14的各種萃取物的實驗結果如表12所示。表12顯示:此分離方法能克服液態-液態分配萃取產生乳化層的問題, 將優格飲品的各類活性成分分離、濃縮集中收集,並得以視覺、嗅覺明顯確認各種萃取物在外觀性狀、風味上的差異。 As shown in the separation method 3 shown in FIG. 5, after a solvent array combination extraction test, finally extraction is performed sequentially with n-hexane, ethyl acetate, ethanol, and water. That is, the Yogurt drink stock solution 12 is freeze-dried to obtain a powdery product 14, and the powdery product 14 is extracted with n-hexane to obtain a n-hexane extract 16 (sample code: 11-H, 12-H, 13-H, 14-H) and the first residue 18. Next, the first residue 18 was extracted with ethyl acetate to obtain an ethyl acetate extract 20 (sample code: 11-E, 12-E, 13-E, 14-E) and a second residue 22. Thereafter, the second residue 22 is extracted with ethanol to obtain an ethanol extract 24 (sample code: 11-A, 12-A, 13-A, 14-A) and a third residue 26. Finally, the third residue 26 is extracted with water to obtain a water extract 28 (sample code: 11-W, 12-W, 13-W, 14-W) and a fourth residue 30. The extract and residue were each concentrated by heating under reduced pressure. The experimental results of various extracts of Yogurt beverages 11 to 14 are shown in Table 12. Table 12 shows that this separation method can overcome the problem of emulsion layer produced by liquid-liquid partition extraction. Various active ingredients of Yogurt were separated, concentrated and collected, and the differences in appearance properties and flavor of various extracts were clearly confirmed by sight and smell.

實驗6、優格飲品萃取物的成分分析:Experiment 6. Composition analysis of Yogurt beverage extract:

1.核磁共振光譜(NMR)分析:1. Nuclear magnetic resonance spectroscopy (NMR) analysis:

優格飲品11至14經分離方法3獲得16個萃取物,將這些萃取物進行NMR分析,以氫的同位素(氘)溶劑:CDCl3、acetone-d6、MeOH-d4、C5D5N、DMSO-d6及D2O測試萃取物的溶解度,結果發現C5D5N、DMSO-d6對於16個萃取物皆有較佳的溶解度。在1H-NMR預實驗中發現C5D5N的溶媒訊號會遮蔽萃取物的訊號,最後選擇DMSO-d6作為NMR分析的溶劑,萃取物的濃度為25mg/ml、50mg/ml、75mg/ml及100mg/ml。發現正己烷萃取物(11-H、12-H、13-H、14-H)、乙酸乙酯萃取物(11-E、12-E、13-E、14-E)、乙醇萃取物(樣品代號:11-A、12-A、13-A、14-A)在50mg/ml時的1H-NMR圖譜顯示出最佳磁場及特徵訊號,水萃取物(11-W、12-W、13-W、14-W)的最佳樣品濃度為25mg/ml。正己烷萃取物(11-H、12-H、13-H、14-H)及乙酸乙酯萃取物(11-E、12-E、13-E、14-E)在加入DMSO-d6後、測試前,加熱至37~40℃能再提高樣品溶解度、進而優化1H-NMR圖譜的特徵訊號。以核磁共振光譜儀JEOL ECS 400MHz FT-NMR進行實驗,解析度為400MHz,化學位移以ppm(δ)表示,偶合常數(coupling constants)以Hertz(J)表示。如第6圖(A)至第9圖(D)的16個萃取物的1H-NMR圖譜及表13的16個萃取物的NMR訊號分析及主量成分判定所示,正己烷萃取物、乙酸乙酯萃取物、乙醇萃取物、水萃取物的NMR特徵訊號及主量成分皆不相同,優格飲品11至14之間的NMR訊號亦有所差異。 Yogurt beverages 11 to 14 are obtained by separation method 3 to obtain 16 extracts. These extracts are subjected to NMR analysis. The hydrogen isotopes (deuterium) solvents are: CDCl 3 , acetone-d6, MeOH-d4, C 5 D 5 N, DMSO-d6 and D 2 O tested the solubility of the extracts. As a result, it was found that C 5 D 5 N and DMSO-d6 had better solubility for 16 extracts. In the 1 H-NMR preliminary experiment, it was found that the solvent signal of C 5 D 5 N would mask the signal of the extract. Finally, DMSO-d6 was selected as the solvent for NMR analysis. The concentration of the extract was 25 mg / ml, 50 mg / ml, 75 mg / ml and 100mg / ml. N-hexane extract (11-H, 12-H, 13-H, 14-H), ethyl acetate extract (11-E, 12-E, 13-E, 14-E), ethanol extract ( Sample code: 11-A, 12-A, 13-A, 14-A) The 1 H-NMR spectrum at 50 mg / ml showed the best magnetic field and characteristic signals. Water extract (11-W, 12-W , 13-W, 14-W) The optimal sample concentration is 25 mg / ml. N-hexane extract (11-H, 12-H, 13-H, 14-H) and ethyl acetate extract (11-E, 12-E, 13-E, 14-E) after adding DMSO-d6 Before testing, heating to 37 ~ 40 ℃ can further improve the solubility of the sample, and then optimize the characteristic signal of the 1 H-NMR spectrum. The experiment was performed with a nuclear magnetic resonance spectrometer JEOL ECS 400MHz FT-NMR. The resolution is 400MHz, the chemical shift is expressed in ppm (δ), and the coupling constants are expressed in Hertz ( J ). As shown in the 1 H-NMR spectra of the 16 extracts in FIGS. 6 (A) to 9 (D), and the NMR signal analysis and main component determination of the 16 extracts in Table 13, the n-hexane extract, The NMR characteristic signals and main components of ethyl acetate extract, ethanol extract, and water extract are all different, and the NMR signals of Yogurt beverages 11 to 14 are also different.

2.總多酚(total polyphenol)含量分析:2. Analysis of total polyphenol content:

優格飲品11至14經分離方法3獲得16個萃取物,將這些萃取物以Folin-Ciocalteu比色法進行分析,其原理為Folin-Ciocalteu試劑中的磷鎢 酸(phosphotungstic acid)及磷鉬酸(phosphomolybdic acid)被多酚類分子氧化呈色,並以没食子酸(gallic acid)作為標準品。實驗方法為:以甲醇溶解没食子酸(5mg/mL)後,製成50、100、250及500μg/mL的標準品,各取20μL標準品以二次水將體積補充至1.6mL,接著加入100μL的2N Folin-Ciocalteu試劑、再加入300μL的20% Na2CO3後並混合,在40℃反應40分鐘,於725nm下測定吸光值。此外另以二次水代替標準品,進行歸零。以濃度及吸光值之關係繪製標準曲線。20μL的待測樣品(1mg/mL)以相同方式處理,依標準曲線計算每克萃取物中總多酚類含量。如表14及第10圖所示的總多酚含量,優格飲品11的萃取物中,11-E含量最高,11-W最低;優格飲品12的萃取物中,12-A含量最高,12-W最低;優格飲品13的萃取物中,13-H含量最高,13-W最低;優格飲品14的萃取物中,14-E含量最高,14-W最低。綜合16個萃取物,14-E的總多酚含量最高,11-W最低。4個正己烷萃取物(11-H至14-H)中,總多酚含量範圍為18.2~24.0mgGallic acid/g。4個乙酸乙酯萃取物(11-E至14-E)中,總多酚含量範圍為9.4~40.6mgGallic acid/g。4個乙醇萃取物(11-A至14-A)中,總多酚含量範圍為11.3~28.3mgGallic acic/g。4個水萃取物(11-W至14-W)中,總多酚含量範圍為2.6~7.1mgGallic acid/g。 Yogurt beverages 11 to 14 are separated into 16 extracts by separation method 3. These extracts are analyzed by the Folin-Ciocalteu colorimetric method. The principle is the phosphotungstic acid and phosphomolybdic acid in the Folin-Ciocalteu reagent (phosphomolybdic acid) is colored by oxidation of polyphenol molecules, and gallic acid is used as a standard. The experimental method is: After dissolving gallic acid (5mg / mL) in methanol, make 50, 100, 250, and 500 μg / mL standards, take 20 μL of each standard to replenish the volume to 1.6 mL with secondary water, and then add 100 μL 2N Folin-Ciocalteu reagent, 300 μL of 20% Na 2 CO 3 was added and mixed, and the mixture was reacted at 40 ° C. for 40 minutes, and the absorbance was measured at 725 nm. In addition, the standard product was replaced by secondary water and zeroed. Draw a standard curve based on the relationship between concentration and absorbance. 20 μL of the test sample (1 mg / mL) was treated in the same way, and the total polyphenol content in each gram of extract was calculated according to the standard curve. As shown in Table 14 and Figure 10, the content of 11-E was highest in the extract of Yogurt Drink 11 and the lowest in 11-W; the content of 12-A was highest in the extract of Yogurt Drink 12, 12-W is the lowest; 13-H content is highest in the extract of Yogurt Drink 13, 13-W is the lowest; 14-E content is highest in the Yogurt Drink 14 extract and 14-W is the lowest. Based on 16 extracts, the total polyphenol content of 14-E was the highest and 11-W was the lowest. In the 4 n-hexane extracts (11-H to 14-H), the total polyphenol content ranged from 18.2 to 24.0 mg Gallic acid / g. In the four ethyl acetate extracts (11-E to 14-E), the total polyphenol content ranged from 9.4 to 40.6 mg Gallic acid / g. In the four ethanol extracts (11-A to 14-A), the total polyphenol content ranged from 11.3 to 28.3 mg Gallic acic / g. In the four water extracts (11-W to 14-W), the total polyphenol content ranged from 2.6 to 7.1 mg of Gallic acid / g.

3.總flavanone類黃酮含量分析:3. Analysis of total flavanone flavonoid content:

原理為2,4-二硝基苯肼(2,4-dinitrophenylhydrazine,DNP)會針對黃烷酮(flavanone)結構上的醛基或酮基進行衍生化,使其在特定波長下具有吸光特性,並以橙皮素(hesperetin)為標準品。實驗方法為:將1mL待測樣品加入2mL的DNP溶液及2mL甲醇,置於50℃水浴加熱50分鐘。冷卻後加入5mL的KOH甲醇溶液混合,室溫下靜置2分鐘,再將1mL混合溶液裝至含5mL甲醇的離心瓶,振盪後以1108×g離心10分鐘。過濾後的上清液以甲醇定量至25mL,並在波長494nm測定吸光值。測定之吸光值與標準品的標準曲線對照定量,換算成每克萃取物之flavanone類黃酮含量。如表14及第11圖所示的總flavanone類黃酮測定結果,優格飲品11的萃取物中,11-A含量最高,11-E最低;優格飲品12的萃取物中,12-A含量最高,12-H最低;優格飲品13的萃取物中,13-A含量最高,13-H最低;優格飲品14的萃取物中,14-A含量最高,14-H最低。綜合16個萃取物,12-A的總flavanone類黃酮含量最高,12-H最低。4個正己烷萃取物(11-H至14-H)中,總flavanone類黃酮含量範圍為15.0~23.1mgHesperetin/g。4個乙酸乙酯萃取物(11-E至14-E)中,總flavanone類黃酮含量範圍為16.0~26.0mgHesperetin/g。4個乙醇萃取物(11-A至14-A)中,總flavanone類黃酮含量範圍為62.5~91.3mgHesperetin/g。4個水萃取物(11-W至14-W)中,總flavanone類黃酮含量範圍為28.2~49.5mgHesperetin/g。 The principle is that 2,4-dinitrophenylhydrazine (DNP) will derivatize the aldehyde group or keto group on the flavanone structure to make it have light absorption properties at a specific wavelength. Hesperetin is used as a standard. The experimental method is as follows: 1 mL of the sample to be tested is added to 2 mL of DNP solution and 2 mL of methanol, and the solution is heated in a 50 ° C water bath for 50 minutes. After cooling, 5 mL of KOH methanol solution was added and mixed, and the mixture was allowed to stand at room temperature for 2 minutes. Then, 1 mL of the mixed solution was charged into a centrifuge bottle containing 5 mL of methanol, and centrifuged at 1108 × g for 10 minutes. The filtered supernatant was quantified to 25 mL with methanol, and the absorbance was measured at a wavelength of 494 nm. The measured absorbance was compared with the standard curve of the standard and quantified, and converted into the flavanone flavonoid content per gram of extract. As shown in Table 14 and Figure 11, the total flavanone flavonoid measurement results showed that the content of 11-A was highest in the extract of Yogurt Drink 11, and the content of 11-E was lowest; the content of 12-A in the extract of Yogurt Drink 12 The highest, 12-H; the extract of Yogurt 13, the highest content of 13-A, the lowest of 13-H; the extract of Yogurt 14, the highest content of 14-A, the lowest of 14-H. Based on 16 extracts, the total flavanone flavonoid content of 12-A was the highest, and 12-H was the lowest. In the 4 n-hexane extracts (11-H to 14-H), the total flavanone flavonoid content ranged from 15.0 to 23.1 mg Hesperetin / g. The content of total flavanone flavonoids in the 4 ethyl acetate extracts (11-E to 14-E) ranged from 16.0 to 26.0 mg Hesperetin / g. In the four ethanol extracts (11-A to 14-A), the total flavanone flavonoid content ranged from 62.5 to 91.3 mg Hesperetin / g. In the four water extracts (11-W to 14-W), the total flavanone flavonoid content ranged from 28.2 to 49.5 mg Hesperetin / g.

4-總多醣含量分析:4- Total polysaccharide content analysis:

此分析是以苯酚-硫酸法(phenol-sulfuric acid assay)進行,原理為五碳糖及六碳糖在酸性、高溫的條件下會因脫水作用分解成喃甲醛(furfural),喃甲醛進一步與酚反應生成橘黃色產物,以吸光值變化換算出總多醣含量,並以0、10、20、30、40、50μg/ml葡萄糖為標準品。實驗方法為:將0.5mL的5%酚溶液加入0.5mL的10mg/mL待測品,再加入2.5mL濃硫酸混合均勻,於100℃水浴反應20分鐘,溫度冷卻後以490nm波長測定吸光值。如表14及第12圖所示的總多醣測定結果,優格飲品11的萃取物中,11-W含量最高,11-H最低;優格飲品12的萃取物中,12-W含量最高,12-E最低;優格飲品13的萃取物中,13-W含量最高,13-H最低;優格飲品14的萃取物中,14-W含量最高,14-H最低。綜合16個萃取物,14-W的總多醣含量最高,14-H最低。4個正己烷萃取物(11-H至14-H)的總多醣含量範圍為7.6~11.2mgGlucose/g。4個乙酸乙酯萃取物(11-E至14-E)的總多醣含量範圍為9.7~18.4mgGlucose/g。4個乙醇萃取物(11-A至14-A)的總多醣含量範圍為223.2~249.4mgGlucose/g。4個水萃取物(11-W至14-W)的總多醣含量範圍為414.4~494.1mgGlucose/g。 This analysis is performed by the phenol-sulfuric acid assay. The principle is that five-carbon sugars and six-carbon sugars are decomposed into furfural due to dehydration under acidic and high temperature conditions. Furfural is further reacted with phenol An orange-yellow product is formed by the reaction, and the total polysaccharide content is converted by changing the absorbance value, and 0, 10, 20, 30, 40, 50 μg / ml glucose is used as a standard. The experimental method is as follows: 0.5 mL of a 5% phenol solution is added to 0.5 mL of a 10 mg / mL test substance, and then 2.5 mL of concentrated sulfuric acid is added, and the mixture is uniformly reacted in a water bath at 100 ° C for 20 minutes. After the temperature is cooled, the absorbance is measured at a wavelength of 490 nm. As shown in Table 14 and Figure 12, the total polysaccharides in the extract of Yogurt 11 have the highest 11-W content and the lowest of 11-H; the extract of Yogurt 12 has the highest 12-W content. 12-E is the lowest; 13-W content is highest in the extract of Yogurt Drink 13, 13-H is the lowest; 14-W content is highest in the extract of Yogurt Drink 14, and 14-H is the lowest. Comprehensive 16 extracts, the total polysaccharide content of 14-W is the highest, and 14-H is the lowest. The total polysaccharide content of the four n-hexane extracts (11-H to 14-H) ranged from 7.6 to 11.2 mg Glucose / g. The total polysaccharide content of the four ethyl acetate extracts (11-E to 14-E) ranged from 9.7 to 18.4 mg Glucose / g. The total ethanol content of the four ethanol extracts (11-A to 14-A) ranged from 223.2 to 249.4 mg Glucose / g. The total polysaccharide content of the four water extracts (11-W to 14-W) ranged from 414.4 to 494.1 mg Glucose / g.

5.薄層層析(TLC)分析:5. Thin layer chromatography (TLC) analysis:

參照台灣中藥典(第二版)中常用的正相薄層層析法進行分析,溶媒系統以離子性溶媒系統(正己烷、二氯甲烷、三氯甲烷、甲醇)或非離子性溶媒系統(正己烷、甲苯、乙酸乙酯、丙酮、甲醇)、以及加酸(冰醋酸(GAA)、甲酸(FA))或加鹼(10%氨、25%氨、二乙胺)搭配進行測試。如表15所示,正己烷萃取物及乙酸乙酯萃取物(11-H、11-E、12-H、12-E、13-H、13-E、14-H、14-E)的極性較為相近,TLC主要斑點能在同一溶媒系統具有良好的分析效果。乙醇萃取物(11-A至14-A)及水萃取物(11-W至14-W)在正相薄層層析中皆無理想的分析效果,TLC主要斑點未能存在於Rf 0.3-0.8。 Refer to the normal phase thin layer chromatography commonly used in Taiwan Chinese Pharmacopoeia (Second Edition) for analysis. The solvent system is ionic solvent system (n-hexane, dichloromethane, chloroform, methanol) or non-ionic solvent system ( Tests were performed with n-hexane, toluene, ethyl acetate, acetone, methanol), and addition of acid (glacial acetic acid (GAA), formic acid (FA)) or addition of base (10% ammonia, 25% ammonia, diethylamine). As shown in Table 15, the n-hexane extract and ethyl acetate extract (11-H, 11-E, 12-H, 12-E, 13-H, 13-E, 14-H, 14-E) The polarities are similar, and the main spots of TLC can have a good analysis effect in the same solvent system. Ethanol extracts (11-A to 14-A) and water extracts (11-W to 14-W) did not have satisfactory results in normal-phase thin-layer chromatography. The main spots of TLC did not exist at R f 0.3- 0.8.

表15、優格飲品11至14經分離方法3獲得的萃取物的正相薄層層析分析 Table 15.Normal Phase Thin Layer Chromatographic Analysis of Extracts from Yogurt Drinks 11 to 14 via Separation Method 3

6.高效液相層析(HPLC)分析:6. High performance liquid chromatography (HPLC) analysis:

參照台灣中藥典(第二版)中常用的逆相高效液相層析法進行分析,條件如下:高效液相層析儀為Agilent 1100系列,偵測器為G1315B光二極體陣列偵測器,自動取樣器為G1329A自動取樣器,層析管柱為Intersil ODS-3V 250 x 4.6mm(5μm),移動相的溶劑A為乙腈、溶劑B為0.1% H3PO4,流速為1ml/min,管柱溫度為30℃,偵測波長為203、210、254、280及365nm。溶媒系統條件如下:移動相包括溶劑A及B、線性梯度為0~20分鐘0% A~10% A,20~40分鐘10% A~40% A,40~60分鐘40% A~100% A,60~70分鐘100% A,流速及管柱溫度如上所述。如表16及第13圖至第16圖所示,5種偵測波長中,正己烷萃取物(11-H至14-H)及乙酸乙酯萃取物(11-E至14-E)皆未觀察到顯著的層析波峰,乙醇萃取物(11-A至14-A)及水萃取物(11-W至14-W)只有203nm呈現較佳的層析波峰。 The analysis was performed with reference to the reversed-phase high-performance liquid chromatography commonly used in Taiwan ’s Chinese Pharmacopoeia (Second Edition). The autosampler is G1329A autosampler, the chromatography column is Intersil ODS-3V 250 x 4.6mm (5μm), the solvent A of the mobile phase is acetonitrile, the solvent B is 0.1% H 3 PO 4 , and the flow rate is 1ml / min. The column temperature is 30 ° C and the detection wavelengths are 203, 210, 254, 280 and 365nm. The conditions of the solvent system are as follows: the mobile phase includes solvents A and B, the linear gradient is 0% to 20 minutes, 0% A to 10% A, 20 to 40 minutes, 10% A to 40% A, and 40 to 60 minutes, 40% A to 100%. A, 100% for 60 to 70 minutes, flow rate and column temperature are as described above. As shown in Table 16 and Figures 13 to 16, among the five detection wavelengths, n-hexane extract (11-H to 14-H) and ethyl acetate extract (11-E to 14-E) are all No significant chromatographic peaks were observed. The ethanol extracts (11-A to 14-A) and water extracts (11-W to 14-W) exhibited better chromatographic peaks only at 203 nm.

實驗7、優格飲品萃取物的抗氧化活性測試:Experiment 7. Antioxidant activity test of Yogurt beverage extract:

1.清除1,1-二苯基-2-三硝基苯肼(2,2-diphenyl-1-pricrylhydrazyl,DPPH)自由基能力測定:1. Determination of 1,1-diphenyl-2-trinitrophenylhydrazine (2,2-diphenyl-1-pricrylhydrazyl, DPPH) free radical capacity:

脂質在自行氧化過程中產生自由基而造成脂質酸敗,抗氧化物藉由提供氫來清除脂質過氧化物自由基,進而抑制氧化連鎖反應。DPPH在抗氧化研究中常被使用來評估抗氧化物的供氫能力。DPPH甲醇溶液在517nm有強吸光,被抗氧化劑還原時吸光值降低。因此,在517nm的吸光值越低表示抗氧化劑的供氫能力越強。實驗方法為:將4mL的萃取物樣品(50mg的萃取物溶於15mL的50%乙醇溶液)加入1mL新鮮配製的10mM DPPH甲醇溶液,振盪混合後置於室溫30分鐘,檢測517nm波長的吸光值。結果以清除百分比表示,清除百分比越高表示測試樣品的供氫能力越佳。 如表17及第17圖所示,萃取物11-A、14-A在16個萃取物中具有較佳的清除DPPH自由基能力。 Lipids produce free radicals during the process of self-oxidation and cause rancidity of lipids. Antioxidants scavenge lipid peroxide free radicals by supplying hydrogen, thereby inhibiting the oxidative chain reaction. DPPH is often used in antioxidant research to evaluate the hydrogen supply capacity of antioxidants. DPPH methanol solution has strong light absorption at 517nm, and the absorption value decreases when it is reduced by the antioxidant. Therefore, the lower the absorbance at 517 nm, the stronger the hydrogen supply ability of the antioxidant. The experimental method is as follows: 4 mL of extract sample (50 mg of extract in 15 mL of 50% ethanol solution) is added to 1 mL of freshly prepared 10 mM DPPH methanol solution, shaken and mixed, and then placed at room temperature for 30 minutes, and the absorbance at 517 nm is measured. . The result is expressed as a percentage of removal, and the higher the percentage of removal, the better the hydrogen supply capacity of the test sample. As shown in Table 17 and Figure 17, extracts 11-A and 14-A have better ability to scavenge DPPH free radicals in 16 extracts.

2.總抗氧化能力(trolox equivalent antioxidant capacity,TEAC)測定:2. Total antioxidant capacity (TEAC) determination:

2,2'-Azinobis-(3-ethylbenzthiazoline-6-sulphonate)(ABTS)在過氧化氫、過氧化酶催化下產生氧化反應,形成穩定的藍綠色水溶性ABTS˙+陽離子自由基。使用紫外光-可見光光度計、在620nm下有較強吸光值,對照標準品水溶性維他命E類似物(trolox)製作標準曲線。當ABTS˙+陽離子自由基與抗氧化劑還原時,溶液顏色會變淺、吸光值降低,從而換算清除ABTS˙+陽離子自由基之能力。清除能力越好表示抗氧化物供氫能力越強。實驗方法為:將配製完成後的ABTS置於冰箱1小時,使其產生穩定的藍綠色ABTS˙+自由基水溶液。將80μL萃取物樣品(50mg的萃取物溶於 15mL的50%乙醇溶液)加入96孔盤,再加入120μL的ABTS˙+自由基水溶液,總體積為200μL。於室溫下避光震盪10分鐘,測定620nm的吸光值。吸光值越低表示清除ABTS˙+自由基效果越佳,以百分比計算清除率。如表17及第18圖所示的總抗氧化能力結果,優格飲品11的萃取物中,11-A能力最佳,11-E最弱;優格飲品12的萃取物中,12-A能力最佳,12-H最弱;優格飲品13的萃取物中,13-A能力最佳,13-H最弱;優格飲品14的萃取物中,14-A能力最佳,14-H最弱。在16個萃取物中,12-A的總抗氧化能力最佳,12-H最弱。 2,2'-Azinobis- (3-ethylbenzthiazoline-6-sulphonate) (ABTS) produces an oxidation reaction under the catalysis of hydrogen peroxide and peroxidase to form a stable blue-green water-soluble ABTS˙ + cationic radical. A UV-Vis photometer was used, which had a strong absorbance at 620 nm, and a standard curve was prepared against a water-soluble vitamin E analog (trolox) of the standard. When ABTS˙ + cationic radicals and antioxidants are reduced, the solution color will become lighter and the absorbance value will be reduced, so that the ability to remove ABTS˙ + cationic radicals will be converted. The better the scavenging ability, the stronger the antioxidant hydrogen supplying ability. The experimental method is as follows: the prepared ABTS is placed in a refrigerator for 1 hour, so that it produces a stable blue-green ABTS˙ + radical aqueous solution. 80 μL of the extract sample (50 mg of the extract in 15 mL of a 50% ethanol solution) was added to a 96-well plate, and 120 μL of ABTS (R) + free radical aqueous solution was added, and the total volume was 200 μL. Shock at room temperature for 10 minutes at room temperature, and measure the absorbance at 620 nm. The lower the absorbance value, the better the effect of scavenging ABTS˙ + free radicals. The clearance rate is calculated as a percentage. As shown in Table 17 and Figure 18, the results of total antioxidant capacity showed that among the extracts of Yogurt 11, 11-A had the best ability and 11-E was the weakest; among the extracts of Yogurt 12, 12-A The best ability, 12-H is the weakest; among the extracts of Yogurt 13, 13-A has the best ability, 13-H is the weakest; among the extracts of Yogurt 14, 14-A has the best ability, 14- H is the weakest. Among the 16 extracts, 12-A had the best total antioxidant capacity, and 12-H was the weakest.

3.還原力測定:3. Determination of reducing power:

抗氧化劑會將赤血鹽(K3Fe(CN)6)還原成黃血鹽(K4Fe(CN)6),黃血鹽再與Fe3+作用生成普魯士藍,在620nm波長測定吸光值,以檢測普魯士藍之生成量,吸光值愈高表示抗氧化劑還原力愈強。實驗方法為:將200μL萃取物樣品(50mg的萃取物溶於15mL的50%乙醇溶液)加入微量離心管,再加入200μL的1%赤血鹽,總體積為400μL。混合後置於50℃水浴槽反應20分鐘,反應完成後置於冰上冷卻10分鐘,再加入200μL的10%三氯乙酸(TCA)混合,以3,000rpm離心10分鐘。將75μL上清液加入96孔盤,再加入75μL超純水及30μL的0.1% FeCl3.6H2O,混合後測定620nm吸光值。吸光值越高代表還原力越強。如表17及第19圖所示,優格飲品11的萃取物中,11-A還原力最佳,11-H及11-E的還原力相等且最弱;優格飲品12的萃取物中,12-A還原力最佳,12-W最弱;優格飲品13的萃取物中,13-A還原力最佳,13-H最弱;優格飲品14的萃取物中,14-A還原力最佳,14-H還原力最弱。在16個萃取物中,12-A還原力最佳,13-H還原力最弱。 Antioxidants will reduce red blood salt (K 3 Fe (CN) 6 ) to yellow blood salt (K 4 Fe (CN) 6 ). Yellow blood salt will then interact with Fe 3+ to form Prussian blue. The absorbance value is measured at a wavelength of 620nm. To detect the amount of Prussian blue produced, the higher the absorbance value, the stronger the antioxidant reducing power. The experimental method is as follows: 200 μL of an extract sample (50 mg of the extract is dissolved in 15 mL of a 50% ethanol solution) is added to a microcentrifuge tube, and then 200 μL of 1% red blood salt is added, and the total volume is 400 μL. After mixing, it was placed in a 50 ° C water bath for 20 minutes. After the reaction was completed, it was cooled on ice for 10 minutes, and then 200 μL of 10% trichloroacetic acid (TCA) was added for mixing, followed by centrifugation at 3,000 rpm for 10 minutes. Add 75 μL of the supernatant to a 96-well plate, and then add 75 μL of ultrapure water and 30 μL of 0.1% FeCl 3 . 6H 2 O, and the absorbance at 620 nm was measured. Higher absorbance means stronger reducing power. As shown in Table 17 and Figure 19, among the extracts of Yogurt Drink 11, the reducing power of 11-A is the best, and the reducing forces of 11-H and 11-E are the same and weakest; among the extracts of Yogurt Drink 12 , 12-A has the best reducing power, 12-W is the weakest; among the extracts of Yogurt 13, 13-A has the best reducing power, 13-H is the weakest; among the extracts of Yogurt 14, 14-A The reducing power is the best, and the 14-H reducing power is the weakest. Among the 16 extracts, the 12-A reducing power was the best, and the 13-H reducing power was the weakest.

實驗8、優格飲品萃取物的抑制癌細胞生長活性測試:Experiment 8: Yogurt Beverage Extract Inhibits Cancer Cell Growth Activity Test:

針對共生菌-腸-腦軸的相關器官,活性代謝物自口腔攝入開始,會經由消化道、血液、循環系統、至泌尿系統(排泄系統),選擇以口 腔癌(Ca9-22、Cal-27細胞株)、血癌(K562、Molt 4細胞株)、腦癌(GBM8401、U87MG細胞株)、胃癌(KATO III、SNU-1細胞株)、大腸癌(DLD-1細胞株)、前列腺癌(LN-cap、PC-3細胞株)進行優格飲品11至14經分離方法3所獲得16個萃取物的抑制癌細胞生長活性測試。實驗方法為細胞存活率分析(MTT assay),將各種癌細胞植入96孔盤,每孔細胞密度為7×103cells/100μL,再加入不同濃度(在100μg/mL之內)的樣品(以DMSO作為控制組),置於37℃、5% CO2細胞培養箱靜置72小時。再加入50μL MTT,培養1小時。以2000rpm離心3分鐘,去除上清液再加入200μL DMSO,置於震盪器上搖晃至紫色結晶完全溶解,讀取570mm及620mm的吸光值。結果呈現為不同樣品以100μg/mL濃度內處理後,最佳抑制癌細胞生長百分比。口腔癌的人體臨床治療以手術、放射治療(電療)為主,本實驗中的16個萃取物未顯示抑制口腔癌細胞生長的效果。其他癌症細胞的實驗結果如表18及第20圖至第24圖所示。 For related organs of the commensal bacteria-gut-brain axis, the active metabolites start from oral intake and pass through the digestive tract, blood, circulatory system, and urinary system (excretion system). Oral cancer (Ca9-22, Cal- 27 cell line), blood cancer (K562, Molt 4 cell line), brain cancer (GBM8401, U87MG cell line), gastric cancer (KATO III, SNU-1 cell line), colorectal cancer (DLD-1 cell line), prostate cancer ( LN-cap, PC-3 cell line) were tested for the activity of inhibiting the growth of cancer cells in 16 extracts obtained from Yogurt Drinks 11 to 14 after separation method 3. The experimental method is cell survival analysis (MTT assay). Various cancer cells are implanted into 96-well disks, and the cell density of each well is 7 × 10 3 cells / 100 μL. DMSO was used as the control group) and placed in a 37 ° C, 5% CO 2 cell incubator for 72 hours. An additional 50 μL of MTT was added and incubated for 1 hour. Centrifuge at 2000 rpm for 3 minutes, remove the supernatant and add 200 μL DMSO, shake on a shaker until the purple crystals are completely dissolved, and read the absorbance at 570 mm and 620 mm. Results are presented as the different samples processed in the 100 μ g / mL concentration, the best percentage of growth inhibition of cancer cells. The human clinical treatment of oral cancer is mainly surgery and radiation therapy (electrotherapy). The 16 extracts in this experiment did not show the effect of inhibiting the growth of oral cancer cells. The experimental results of other cancer cells are shown in Table 18 and Figures 20 to 24.

1.抑制血癌細胞(K562、Molt 4細胞株)的生長活性:1. Inhibiting the growth activity of blood cancer cells (K562, Molt 4 cell lines):

如第20圖所示,在抑制血癌細胞K562生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-A的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-W的抑制活性最佳,13-H最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-W最弱。綜合16個萃取物中,12-A的抑制癌細胞生長活性最佳。如第20圖所示,在抑制血癌細胞Molt 4生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-E、11-W皆無抑制活性;優格飲品12的萃取物中,12-A的抑制活性最佳,12-H、12-W皆無抑制活性;優格飲品13的萃取物中,13-A的抑制活性最佳,13-E最弱;優格飲品14的萃取物中,14-E的抑制活性最佳,14-A、14-W皆無抑制活性。綜合16個萃取物中,14-E的抑制活性最佳。 As shown in Figure 20, in terms of inhibiting the growth of blood cancer cells K562, 11-A had the best inhibitory activity, and 11-W had the weakest extract. Among the extracts of Yogurt Drink 12, 12- A had the best inhibitory activity, 12-W was the weakest; among the extracts of Yogurt 13, 13-W had the best inhibitory activity, 13-H was the weakest; among the extracts of Yogurt 14, 14-A The inhibitory activity was the best, and 14-W was the weakest. Among 16 extracts, 12-A had the best inhibitory activity against cancer cell growth. As shown in Figure 20, in terms of inhibiting the growth of blood cancer cell Molt 4, among the extracts of Yogurt Drink 11, 11-H had the best inhibitory activity, and 11-E and 11-W had no inhibitory activity. Among the extracts, 12-A had the best inhibitory activity, and 12-H and 12-W had no inhibitory activity. Among the extracts of Yogurt 13, 13-A had the best inhibitory activity, and 13-E was the weakest; Yogurt Among the extracts of drink 14, 14-E had the best inhibitory activity, and 14-A and 14-W had no inhibitory activity. Among 16 extracts, 14-E had the best inhibitory activity.

2.抑制腦癌細胞(GBM8401、U87MG細胞株)生長活性:2. Inhibit the growth activity of brain cancer cells (GBM8401, U87MG cell lines):

如第21圖所示,在抑制腦癌細胞GBM8401生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-E最弱;優格飲品12的萃取物中,12-A的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-W最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-H最弱。綜合16個萃取物中,11-A的抑制活性最佳。如第21圖所示,在抑制細胞U87MG生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-E、13-W皆無抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-E最弱。綜合16個萃取物中,14-W的抑制活性最佳。 As shown in Figure 21, in inhibiting the growth of brain cancer cell GBM8401, among the extracts of Yogurt 11, 11-A had the best inhibitory activity, and 11-E was the weakest. Among the extracts of Yogurt 12, 12 -A had the best inhibitory activity, 12-W was the weakest; among the extracts of Yogurt 13, 13-H had the best inhibitory activity, 13-W was the weakest; among the extracts of Yogurt 14, 14-A The best inhibitory activity was 14-H. Among the 16 extracts, 11-A had the best inhibitory activity. As shown in Figure 21, in terms of inhibiting the growth of cells U87MG, 11-A had the best inhibitory activity and 11-W was the weakest in the extract of Yogurt 11; 12-H in the extract of Yogurt 12 The best inhibitory activity is 12-W, and the weakest is 12-W. Among the extracts of Yogurt 13, 13-H has the best inhibitory activity, and neither 13-E, 13-W has inhibitory activity. 14-W had the best inhibitory activity, and 14-E had the weakest. Among 16 extracts, 14-W had the best inhibitory activity.

3.抑制胃癌細胞(KATO III、SNU-1細胞株)生長活性:3. Inhibit the growth activity of gastric cancer cells (KATO III, SNU-1 cell lines):

如第22圖所示,在抑制胃癌細胞KATO III生長方面,優格飲 品11的萃取物中,11-H的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-E的抑制活性最佳,12-H、12-W皆無抑制活性;優格飲品13的萃取物中,只有13-E具有抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-A最弱。綜合16個萃取物中,14-W的抑制活性最佳。如第22圖所示,在抑制胃癌細胞SNU-1生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-A最弱;優格飲品12的萃取物中,12-E的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-A最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-E最弱。綜合16個萃取物中,12-E的抑制活性最佳。 As shown in Figure 22, in suppressing the growth of gastric cancer cell KATO III, Among the extracts of Pin 11, 11-H had the best inhibitory activity, and 11-W was the weakest. Among the extracts of Yogurt 12, 12-E had the best inhibitory activity, and 12-H and 12-W had no inhibitory activity. ; Among the extracts of Yogurt Drink 13, only 13-E has inhibitory activity; among the extracts of Yogurt Drink 14, 14-W has the best inhibitory activity and 14-A has the weakest. Among 16 extracts, 14-W had the best inhibitory activity. As shown in Figure 22, in inhibiting the growth of gastric cancer cells SNU-1, the extract of Yogurt 11 has the best inhibitory activity, and 11-A is the weakest. Among the extracts of Yogurt 12, 12-E had the best inhibitory activity, 12-W was the weakest; among the extracts of Yogurt 13, 13-H had the best inhibitory activity, 13-A was the weakest; among the extracts of Yogurt 14, 14- A had the best inhibitory activity, and 14-E was the weakest. Among 16 extracts, 12-E had the best inhibitory activity.

4.抑制大腸癌細胞(DLD-1細胞株)生長活性:4. Inhibition of colorectal cancer cell (DLD-1 cell line) growth activity:

如第23圖所示,在抑制大腸癌細胞DLD-1生長方面,優格飲品11的萃取物中,11-H的抑制活性最佳,11-W最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-E最弱;優格飲品13的萃取物中,13-H的抑制活性最佳,13-W最弱;優格飲品14的萃取物中,14-A的抑制活性最佳,14-E最弱。綜合16個萃取物中,11-A的抑制活性最佳。 As shown in Figure 23, in inhibiting the growth of colorectal cancer cells DLD-1, among the extracts of Yogurt Drink 11, 11-H had the best inhibitory activity and 11-W was the weakest; among the extracts of Yogurt Drink 12 , 12-H has the best inhibitory activity, 12-E is the weakest; among the extracts of Yogurt 13, 13-H has the best inhibitory activity, 13-W is the weakest; -A had the best inhibitory activity, and 14-E had the weakest. Among the 16 extracts, 11-A had the best inhibitory activity.

5.抑制前列腺癌細胞(LN-cap、PC-3細胞株)生長活性:5. Inhibition of prostate cancer cell (LN-cap, PC-3 cell line) growth activity:

如第24圖所示,在抑制前列腺癌細胞LN-cap生長方面,優格飲品11的萃取物中,11-A的抑制活性最佳,11-E最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-E最弱;優格飲品13的萃取物中,13-A的抑制活性最佳,13-H、13-E皆無抑制活性;優格飲品14的萃取物中,14-W的抑制活性最佳,14-H最弱。綜合16個萃取物中,11-A的抑制活性最佳。如第24圖所示,在抑制前列腺癌細胞PC-3生長方面,優格飲品11的萃取物中,11-E的抑制活性最佳,11-H最弱;優格飲品12的萃取物中,12-H的抑制活性最佳,12-W最弱;優格飲品13的萃取物中,13-E的抑制活性最佳,13-H、13-W皆無抑制活性;優格飲品14的萃取物中,14-E的抑制活性最佳,14-A最弱。綜合16個萃取物中,13-E的抑制活性最佳。 As shown in Figure 24, in inhibiting the growth of prostate cancer cells LN-cap, among the extracts of Yogurt 11, 11-A had the best inhibitory activity, and 11-E was the weakest; among the extracts of Yogurt 12 , 12-H had the best inhibitory activity, and 12-E was the weakest. Among the extracts of Yogurt Drink 13, 13-A had the best inhibitory activity, and 13-H and 13-E had no inhibitory activity. In the extract, 14-W had the best inhibitory activity, and 14-H had the weakest. Among the 16 extracts, 11-A had the best inhibitory activity. As shown in Figure 24, in inhibiting the growth of prostate cancer cells PC-3, 11-E had the best inhibitory activity and 11-H was the weakest among the extracts of Yogurt Drink 11; among the extracts of Yogurt Drink 12 , 12-H had the best inhibitory activity, and 12-W was the weakest. Among the extracts of Yogurt Drink 13, 13-E had the best inhibitory activity, and 13-H and 13-W had no inhibitory activity. Among the extracts, 14-E had the best inhibitory activity, and 14-A had the weakest. Among 16 extracts, 13-E had the best inhibitory activity.

實驗9、優格飲品生產系統:Experiment 9. Yogurt beverage production system:

過去的液態優格飲品在生產上分為二種形式:家庭式自製小量生產以及噸級工廠大量生產。家庭式小量生產有品質不穩定、需後續調製、操作不便的問題。噸級工廠大量生產會面臨從消費者購買及飲用飲品時已經過2至3天或以上,新鮮發酵的優格飲品無法被當日飲用,且常有無法在保存期限內喝完、或保存不當變質的問題。因此,本發明提供一種液態優格飲品的生產系統,能同時解決上述家庭式自製小量生產、噸級工廠大量生產優格飲品的問題,以單一發酵機就能生產公斤級液態優格飲品,能在現場以透明化製程發酵製作,於18小時完成,讓消費者每天飲用的優格飲品皆為當日新鮮發酵現做,終端產品以手搖飲方式出餐。 In the past, liquid yogurt beverages were produced in two forms: home-made small-scale production and mass production in tonnage factories. The family-type small-scale production has the problems of unstable quality, subsequent modulation and inconvenient operation. The mass production of ton-scale factories will face 2 to 3 days or more when consumers buy and drink beverages. Freshly fermented Yogurt beverages cannot be consumed on the same day, and often they cannot be consumed within the storage period, or are stored improperly. The problem. Therefore, the present invention provides a production system for liquid yogurt, which can simultaneously solve the above-mentioned problems of home-made small-scale production and mass production of yogurt in tonnage factories. A single fermentation machine can produce kilogram liquid yogurt. It can be fermented on-site in a transparent process and completed in 18 hours. The Yogurt drinks that consumers consume every day are freshly fermented on the day, and the end products are eaten by hand.

如第25圖所示的製程及第26圖所示的發酵機100的結構,本發明液態優格飲品生產系統的依序包括:高壓清洗、高溫滅菌、製奶乳化、二次滅菌、接菌發酵、成品抽樣、成品收槽、降溫冷藏、均質調製、加入配料、充填包裝、產品出餐。 As shown in the process shown in FIG. 25 and the structure of the fermenter 100 shown in FIG. 26, the sequence of the liquid yogurt beverage production system of the present invention includes: high-pressure cleaning, high temperature sterilization, milk emulsification, secondary sterilization, and inoculation. Fermentation, finished product sampling, finished product collection, cooling and refrigerating, homogeneous preparation, adding ingredients, filling and packaging, and product meals.

用於製備優格飲品的發酵機100包括:槽體101、與槽體101組裝的密封頂蓋105、設置於密封頂蓋105上的投料口M、設置於槽體101外的電機控制器108、耦接於電機控制器108的攪拌馬達110、設置於槽體101空間內且連接於攪拌馬達110的攪拌臂104、設置於槽體101外且耦接於電機控制器108的電阻增溫器103。其中,密封頂蓋105與槽體101所圍設的空間為密閉狀態;水、奶粉以及菌粉經由投料口M被送入該空間內;電阻增溫器103用以消毒水及奶粉,並使菌粉在水以及奶粉所形成的混合物中於37℃至43℃之間受攪拌臂104攪拌而製備成優格飲品。 The fermentation machine 100 for preparing yogurt drinks includes a tank 101, a sealed top cover 105 assembled with the tank 101, a feeding port M provided on the sealed top cover 105, and a motor controller 108 provided outside the tank 101. A stirring motor 110 coupled to the motor controller 108, a stirring arm 104 disposed in the space of the tank 101 and connected to the stirring motor 110, a resistance warmer disposed outside the tank 101 and coupled to the motor controller 108 103. Among them, the space enclosed by the sealed top cover 105 and the tank 101 is in a closed state; water, milk powder and bacterial powder are sent into the space through the feeding port M; the resistance warmer 103 is used to disinfect water and milk powder, and The fungus powder is stirred by the stirring arm 104 in a mixture of water and milk powder at 37 ° C to 43 ° C to prepare a yogurt beverage.

進一步而言,發酵機100還包括設置於槽體101底部、而供該優格飲品或廢液(或廢水)排出的出料口N4。替代地,發酵機100還包括設置於槽體101外且與電阻增溫器103連接的控溫夾層102,該控溫夾層102用以受電阻增溫器103的控制而調整或維持空間內的溫度。替代地,密封頂蓋 105上還包括清洗口106,發酵機100還包括設置於槽體101側邊的導熱流入口N5以及底部的導熱流出口N6。替代地,發酵機100還包括耦接於電機控制器108的感溫探測器107,且感溫探測器107感測的溫度顯示於電機控制器108的螢幕109上。替代地,密封頂蓋105上的觀察窗S1可供使用者目視槽體101內的狀況。 Further, the fermenter 100 further includes a discharge port N4 provided at the bottom of the tank 101 and for discharging the Yogurt beverage or waste liquid (or waste water). Alternatively, the fermenter 100 further includes a temperature-controlling interlayer 102 disposed outside the tank 101 and connected to the resistance warmer 103, and the temperature-controlling interlayer 102 is used to adjust or maintain the space in the space under the control of the resistance warmer 103. temperature. Alternatively, seal the top cover 105 further includes a cleaning port 106, and the fermenter 100 further includes a heat conduction inlet N5 and a heat conduction outlet N6 at the bottom of the tank 101. Alternatively, the fermentation machine 100 further includes a temperature detector 107 coupled to the motor controller 108, and the temperature detected by the temperature detector 107 is displayed on the screen 109 of the motor controller 108. Alternatively, the observation window S1 on the sealed top cover 105 allows the user to visually observe the condition in the groove body 101.

第25圖的製程如下所述: The process of Figure 25 is as follows:

(1)高壓清洗、高溫滅菌:打開投料口M→使用高壓噴槍對槽體101內壁進行清理→由觀察窗S1確認水位高度至適當位置→開啟出料口N4排放→槽體101再次加滿水→感溫探測器107偵測到的溫度顯示於電機控制器108的螢幕109→顯示加熱至72℃以上→達到滅菌溫度後→靜置30分鐘→開啟出料口N4排放至廢水槽(未示出)。 (1) High-pressure cleaning and high-temperature sterilization: open the feeding port M → use a high-pressure spray gun to clean the inner wall of the tank 101 → confirm that the water level is in an appropriate position through the observation window S1 → open the discharge port N4 to discharge → the tank 101 is full again Water → The temperature detected by the temperature detector 107 is displayed on the screen 109 of the motor controller 108 → The display is heated to above 72 ° C → After reaching the sterilization temperature → Let it stand for 30 minutes → Open the discharge port N4 and discharge to the waste water tank (not Shows).

(2)製奶乳化:打開投料口M→注入潔淨水→投入奶粉→開啟攪拌馬達110→進行乳化→關閉投料口M→由觀察窗S1確認乳化情況。 (2) Milk-making emulsification: Open the feeding port M → inject clean water → add milk powder → turn on the stirring motor 110 → perform emulsification → close the feeding port M → confirm the emulsification situation through the observation window S1.

(3)二次滅菌:開啟加溫→觀察螢幕109顯示加熱至72℃以上→達到滅菌溫度後→關閉加溫→靜置30分鐘。 (3) Secondary sterilization: turn on the heating → observe the screen 109 shows that it is heated to above 72 ° C → after reaching the sterilization temperature → turn off the heating → leave it for 30 minutes.

(4)接菌發酵:將冷卻水由導熱流入口N5注入→開啟循環泵(未示出)→以冷卻水進行熱交換控溫→觀察螢幕109顯示逐步降溫至43℃→關閉冷卻水源與循環泵→投料口M以75%酒精消毒→迅速打開投料口M投菌並且關閉旋緊→開啟攪拌馬達110使攪拌臂104運轉攪拌20分鐘→關閉攪拌馬達110→靜置發酵。 (4) Bacteria fermentation: Inject cooling water from the heat conduction inlet N5 → turn on the circulation pump (not shown) → use the cooling water for heat exchange temperature control → observe the screen 109 to gradually reduce the temperature to 43 ° C → close the cooling water source and circulation Pump → Feeding port M is sterilized with 75% alcohol → Quickly open feeding port M to add bacteria and turn off and tighten → Turn on the stirring motor 110 to stir the stirring arm 104 for 20 minutes → Turn off the stirring motor 110 → Allow to stand for fermentation.

(5)成品抽樣:以純淨水噴灑出料口N4再噴灑75%酒精消毒→取出300毫升樣品→進行黏度、pH值檢測→黏度、pH值達收槽標準→進行收槽。 (5) Finished product sampling: spray the outlet N4 with pure water and spray with 75% alcohol to sterilize → take out a 300 ml sample → check the viscosity and pH value → the viscosity and pH value reach the tank collection standard → perform tank collection.

(6)成品收槽:以純淨水噴灑出料口N4→噴灑75%酒精消毒→使用304食品級不銹鋼容器分批盛接。 (6) Finishing tank: spray the outlet N4 with pure water → spray with 75% alcohol for disinfection → use 304 food grade stainless steel containers for batch receiving.

(7)降溫冷藏:優格飲品放量製備→4℃冷藏。 (7) Cooling and refrigerating: Youge drink volume preparation → 4 ℃ refrigerating.

(8)均質調製、加入配料:取優格飲品→加入冰塊→使用均質機進行均 質→固態配料或固態水果配料進行調製。 (8) Homogenize and add ingredients: take Yogurt drink → add ice cube → use homogenizer for homogenization Quality → solid ingredients or solid fruit ingredients.

(9)充填包裝、產品出餐:最後再次檢查飲品或配料是否有滲出→完成。 (9) Filling and packaging, product delivery: Finally, check whether the beverage or ingredients have leaked out again → complete.

本創作實屬難能的創新創作,深具產業價值,援依法提出申請。此外,本創作可以由所屬技術領域中具有通常知識者做任何修改,但不脫離如所附申請專利範圍所要保護的範圍。 This creation is really an incompetent creative creation, which is of great industrial value. In addition, the present creation can be modified in any way by those with ordinary knowledge in the technical field to which it belongs, without departing from the scope to be protected by the scope of the attached patent application.

【序列表】[Sequence list]

<110> 宇洋生物醫學股份有限公司 <110> Yuyang Biomedical Co., Ltd.

<120> 優格生技飲品的發酵機 <120> Fermenter for Yogurt Biotech Drinks

<160> 2 <160> 2

<210> 1 <210> 1

<211> 1478 <211> 1478

<212> rDNA <212> rDNA

<213> 發酵乳桿菌(Lactobacillus fermentum) <213> Lactobacillus fermentum

<220> <220>

<223> 菌種代號UY-58的16S rDNA <223> 16S rDNA of strain code UY-58

<400> 1

Figure TWM587175U_D0029
Figure TWM587175U_D0030
<400> 1
Figure TWM587175U_D0029
Figure TWM587175U_D0030

<210> 2 <210> 2

<211> 1515 <211> 1515

<212> rDNA <212> rDNA

<213> 瑞士乳桿菌(Lactobacillus helveticus) <213> Lactobacillus helveticus

<220> <220>

<223> 菌種代號UY-76的16S rDNA <223> 16S rDNA of strain UY-76

<400> 2

Figure TWM587175U_D0031
<400> 2
Figure TWM587175U_D0031

Claims (6)

一種用於製備優格飲品的發酵機,包括:一槽體;一密封頂蓋,與該槽體組裝,使該密封頂蓋與該槽體所圍設的一空間為密閉;一投料口,設置於該密封頂蓋上,俾水、奶粉以及菌粉經由該投料口被送入該空間;一電機控制器,設置於該槽體外;一攪拌馬達,耦接於該電機控制器;一攪拌臂,設置於該空間內且連接於該攪拌馬達,用以攪拌該水、該奶粉以及該菌粉;以及一電阻增溫器,設置於該槽體外且耦接於該電機控制器,用以消毒該水及該奶粉,並使該菌粉在該水以及該奶粉所形成的一混合物中於37℃至43℃之間進行發酵,製備成該優格飲品。A fermentation machine for preparing yogurt drinks, comprising: a tank body; a sealed top cover assembled with the tank body so that a space enclosed by the sealed top cover and the tank body is closed; a feeding port, Set on the sealed top cover, water, milk powder and bacterial powder are sent into the space through the feeding port; a motor controller is installed outside the tank; a stirring motor is coupled to the motor controller; a stirring An arm disposed in the space and connected to the stirring motor for stirring the water, the milk powder, and the fungus powder; and a resistance warmer provided outside the tank and coupled to the motor controller for The water and the milk powder are sterilized, and the bacteria powder is fermented in a mixture formed by the water and the milk powder at 37 ° C to 43 ° C to prepare the yogurt drink. 如申請專利範圍第1項所述的發酵機,其中該發酵機還包括設置於該槽體底部的一出料口,用以供該優格飲品由該出料口送出。The fermenter according to item 1 of the scope of patent application, wherein the fermenter further comprises a discharge port provided at the bottom of the tank for the Yogurt beverage to be sent out from the discharge port. 如申請專利範圍第1項所述的發酵機,其中該發酵機還包括設置於該槽體外的一控溫夾層,且該電阻增溫器與該控溫夾層連接,該控溫夾層用以受該電阻增溫器的控制而調整或維持該空間的溫度。The fermenter according to item 1 of the scope of patent application, wherein the fermenter further comprises a temperature-controlling interlayer disposed outside the tank, and the resistance warmer is connected to the temperature-controlling interlayer, and the temperature-controlling interlayer is used for receiving The resistance warmer is controlled to adjust or maintain the temperature of the space. 如申請專利範圍第1項所述的發酵機,其中該密封頂蓋上還包括清洗口,該發酵機還包括設置於槽體側邊的一導熱流入口以及槽體底部的一導熱流出口。The fermenter according to item 1 of the patent application scope, wherein the sealed top cover further includes a cleaning port, and the fermenter further includes a heat conduction flow inlet disposed at a side of the tank body and a heat conduction flow outlet at a bottom of the tank body. 如申請專利範圍第1項所述的發酵機,其中該發酵機還包括耦接於該電機控制器的感溫探測器,且該電機控制器還包括一螢幕,該感溫探測器感測的一溫度顯示該螢幕上。The fermenter according to item 1 of the patent application scope, wherein the fermenter further comprises a temperature detector coupled to the motor controller, and the motor controller further includes a screen, the temperature sensor detects the A temperature is displayed on the screen. 如申請專利範圍第1項所述的發酵機,其中密封頂蓋還包括一觀察窗,用以供一使用者目視該槽體內的狀況。The fermenter according to item 1 of the patent application scope, wherein the sealed top cover further includes an observation window for a user to visually observe the condition in the tank.
TW108209275U 2019-07-12 2019-07-12 Fermenter of the yogurt bio beverage TWM587175U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108209275U TWM587175U (en) 2019-07-12 2019-07-12 Fermenter of the yogurt bio beverage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108209275U TWM587175U (en) 2019-07-12 2019-07-12 Fermenter of the yogurt bio beverage

Publications (1)

Publication Number Publication Date
TWM587175U true TWM587175U (en) 2019-12-01

Family

ID=69584650

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108209275U TWM587175U (en) 2019-07-12 2019-07-12 Fermenter of the yogurt bio beverage

Country Status (1)

Country Link
TW (1) TWM587175U (en)

Similar Documents

Publication Publication Date Title
Hussein et al. Impact of chickpea as prebiotic, antioxidant and thickener agent of stirred bio-yoghurt
Amorim et al. Probiotic potential of yeasts isolated from pineapple and their use in the elaboration of potentially functional fermented beverages
Anuyahong et al. Incorporation of anthocyanin-rich riceberry rice in yogurts: Effect on physicochemical properties, antioxidant activity and in vitro gastrointestinal digestion
KR101239806B1 (en) The new Lactobacillus plantarum HY7712 stimulate immunity
HU228050B1 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
Farag et al. Rediscovering acidophilus milk, its quality characteristics, manufacturing methods, flavor chemistry and nutritional value
KR20120034482A (en) Lactobacillus plantarum ky1032 having inhibitory activity against adipocyte-specific gene expression and adipocyte differentiation, and product containing thereof as an effective factor
Ravindran Probiotic oats milk drink with microencapsulated Lactobacillus plantarum–an alternative to dairy products
Mazzaglia et al. The influence of almond flour, inulin and whey protein on the sensory and microbiological quality of goat milk yogurt
Gomes et al. Fruit-based non-dairy beverage: A new approach for probiotics
Rocks et al. Possible use of fermented foods in rehabilitation of anorexia nervosa: the gut microbiota as a modulator
Kemsawasd et al. Survival of probiotics in soyoghurt plus mulberry (cv Chiang Mai 60) leaf extract during refrigerated storage and their ability to tolerate gastrointestinal transit
Goderska et al. Evaluation of probiotics in vegetable juices: tomato (Solanum lycopersicum), carrot (Daucus carota subsp. sativus) and beetroot juice (Beta vulgaris)
CN109715181A (en) Bacterium
Praia et al. Coconut water-based probiotic drink proposal: evaluation of microbio-logical stability and lactic acid estimation
Gooch et al. Where tradition meets science: microbial diversity and bioactive compounds in Armenian fermented milk products
CN212382028U (en) Fermentation machine of sour milk raw technology drink
KR101266328B1 (en) Lactobacillus gasseri HY7021 having inhibitory activity against adipocyte-specific gene expression and adipocyte differentiation, and product containing thereof as an effective factor
CN112205473A (en) Yoghourt biotechnological beverage with functions of resisting oxidation and inhibiting growth of digestive tract cancer cells and preparation method thereof
TWI835820B (en) Yogurt bio beverage for anti-oxidation and anti-proliferation against human digestive tract cancer cell lines, and its preparation method
TW202102120A (en) Semisolid yogurt for anti-oxidation and anti-proliferation against human prostate cancer cell lines, and its preparation method
TWM587175U (en) Fermenter of the yogurt bio beverage
Lavermicocca et al. Table olives: a carrier for delivering probiotic bacteria to humans
Abdelshafy et al. Moringa leaves for improving the health benefits of quinoa fermented by probiotics
US20230233624A1 (en) Composition for use in suppressing or improving depression